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10.4 million people are diagnosed with tuberculosis, worldwide, every year, according to 
the World Health Organisation. Mycobacterium tuberculosis is a Gram-positive bacterial 
pathogen that can easily be transmitted to health care professionals and people supplying 
aid in these nations. Fortunately, over the last 100 years, the bacteriophage has gained 
traction as a suitable therapeutic, antibiotic-alternative against bacterial pathogens, such 
as M. tuberculosis. Herein I describe my work utilising endolysins the lytic protein that 
bacteriophages usually employ to burst out of the cell, but instead using these proteins to 
lyse “from without”. In order to develop a proof-of-principle product, we used the 
expansive M. smegmatis bacteriophage collection and chose eight endolysin candidates 
for testing against M. smegmatis. These endolysins were bioinformatically analysed for 
active domains before being synthesised and inserted into an expression vector to produce 
fused biodegradable nanobeads made of polyhydroxyalkanoate. These nanobeads were 
tested for activity against M. smegmatis, a safe mycobacterium closely related to 
pathogenic tuberculosis. Four distinct tests were carried out to test the efficiency of these 
beads in causing cell death in different situations (45 minutes and 5 hours, across 
concentrations of 10mg/ml, 20mg/ml and 80mg/ml. Ultimately the nanobead fusions of 
endolysin Inca (lysin B) caused the most cell death at 80mg/ml after exposure to M. 
smegmatis for 5 hours in a standing culture, at 78.87% cell death ± 5.21. When the 
nanobeads were applied to filter paper to mimic application to a hospital mask as a proof-
of-concept approach before spraying with a bacterial aerosol, we saw that endolysin 
nanobead Jaws (lysin B) caused the most cell death with 75.54% ± 3.15 at 80mg/ml. 
These results are promising and present a unique opportunity to take advantage of an 
existing natural mechanism to use as a prophylactic defense against pathogenic bacteria 




First and foremost, I wish to acknowledge the wisdom and support of my supervisor and Chief 
Phage Hunter, Dr. Heather Hendrickson, whom opened my eyes to the small and incredibly 
versatile world of the humble bacteriophage. Her intellectual challenges and ongoing support 
throughout this research have enabled me to grow and succeed in many ways. 
Secondly, I would also like to acknowledge Dr. Eric Altermann, Kerri Reilly and the team at 
AgResearch, Palmerston North, for taking me under their wing and guiding me through the 
fascinating world of biodegradable nanobeads and their potential to save the world. 
I would also like to acknowledge my parents, Johanne and James, for the hours of devotion 
listening to my trials and tribulations, encouraging me to keep going and accompanying me to the 
laboratory in the evenings when a zombie movie has made me second guess my research path. 
Additionally, to my friends and colleagues who have been there through each practice talk, phage 
pun, mid-thesis crisis and procrastination lunch, I extend my sincere gratitude to you. 
My amazing friend Piper was my inspiration for beginning this field of research to find an 
antibiotic alternative to support her as she dealt with her unfair share of life-threatening bacterial 
infections. I dedicate this thesis to her and my best friend Chiff, who was and will always be, my 
shining light, who started this journey by my side and ended it in my heart. Last but not least my 
late family members Aunty Trish and Taid who would always encourage me to succeed and 




List of figures .......................................................................................................................................... v 
List of tables .......................................................................................................................................... vi 
List of abbreviations ............................................................................................................................ vii 
1 Introduction ....................................................................................................................................... 1 
1.1 Bacterial infection of Mycobacterium species ............................................................................ 1 
1.1.1 Implications of untreated Mycobacterium in New Zealand ............................................... 2 
1.1.2 Diagnosis and treatment of tuberculosis ............................................................................ 3 
1.2 Antibiotic resistant tuberculosis.................................................................................................. 4 
1.3 Transmission of tuberculosis ...................................................................................................... 4 
1.3.1 Infection of health-care workers ........................................................................................ 5 
1.4 Bacteriophages ............................................................................................................................ 7 
1.4.1 Bacteriophage life cycle ..................................................................................................... 7 
1.4.2 Bacterial resistance to bacteriophages................................................................................ 8 
1.5 Gram-positive cell walls ........................................................................................................... 13 
1.6 Endolysins ................................................................................................................................ 14 
1.6.1 D29 mycobacteriophage lysin B demonstrates cell lysis from without ........................... 16 
1.6.2 Endolysin diversity .......................................................................................................... 18 
1.6.3 Advantages of endolysins ................................................................................................ 18 
1.6.4 Complications associated with endolysins ....................................................................... 19 
1.7 Mycobacterium smegmatis mc2155 as a model organism ......................................................... 20 
1.8 PhagesDB.org ........................................................................................................................... 21 
1.9 Mycobacteriophage clusters ..................................................................................................... 24 
1.10 Biodegradable nanobeads ......................................................................................................... 24 
1.10.1 PHA biodegradability ...................................................................................................... 25 
1.10.2 PHA synthase ................................................................................................................... 26 
1.11 Aims ......................................................................................................................................... 27 
1.12 Summary for remainder of the thesis ........................................................................................ 29 
2 Materials and Methods ................................................................................................................... 30 
2.1 Bacteriophage endolysin selection through bioinformatics ...................................................... 30 
2.1.1 Online databases and tools; PhagesDB and NCBI BLASTp annotations ........................ 30 
2.1.2 Clustal Omega .................................................................................................................. 30 
2.1.3 HHpred ............................................................................................................................. 31 
2.1.4 Plasmid constructs ........................................................................................................... 32 
2.2 Media ........................................................................................................................................ 33 
2.2.1 Antibiotics, supplements, media, ..................................................................................... 33 
2.2.2 Bacterial strains ................................................................................................................ 33 
2.2.3 M. smegmatis growth ....................................................................................................... 33 
2.2.4 Growing and maintaining bacteriophage ......................................................................... 34 
iv 
 
2.2.5 Transforming chemically-competent E. coli BL21 .......................................................... 34 
2.3 Nanobead production ................................................................................................................ 34 
2.3.1 Nile Red stain ................................................................................................................... 36 
2.3.2 Bead extraction ................................................................................................................ 36 
2.3.3 Ultrasonic Processor ........................................................................................................ 36 
2.3.4 Bead purification and storage .......................................................................................... 37 
2.4 Testing cell death of M. smegmatis .......................................................................................... 37 
2.4.1 Test one: detecting cell death through fluorescent microscopy ....................................... 38 
2.4.2 Test two: detecting cell death through a plate-reader assay ............................................. 39 
2.4.3 Test three: detecting difference in colony counts ............................................................. 40 
2.4.4 Test four: detecting cell death using filter paper for a proof-of-concept applied approach
 41 
2.4.5 Statistical analysis ............................................................................................................ 42 
3 Results and Discussion .................................................................................................................... 43 
3.1 PART ONE: Gene selection process and domain confirmation ............................................... 43 
3.1.1 Rationale behind choosing the final mycobacteriophage endolysin candidates ............... 43 
3.1.2 Checking for evidence of lysin function using NCBI BLASTp ....................................... 48 
 Bacteriophage selection candidates .......................................................................................... 48 
3.1.3 ................................................................................................................................................... 48 
3.1.4 Verifying lysin-like domains are present using HHpred .................................................. 51 
3.1.5 PhaC pET-14b plasmid construct..................................................................................... 55 
3.2 PART TWO: Expression and production of biodegradable lysin nanobeads ........................... 57 
3.2.1 Establishing expression of PhaC in E. coli with a Nile Red stain .................................... 57 
3.2.2 Purifying nanobeads ......................................................................................................... 58 
3.2.3 Dealing with contamination ............................................................................................. 59 
3.2.4 Endolysin nanobead size differences ............................................................................... 61 
3.3 PART THREE: Testing antimicrobial activity against M. smegmatis ...................................... 67 
3.3.1 Test one: detecting cell death through fluorescent microscopy ....................................... 67 
3.3.2 Test two: detecting cell death through a plate-reader assay ............................................. 73 
3.3.3 Test three: detecting difference in colony counts ............................................................. 78 
3.3.4 Test four: detecting cell death using hospital masks as a proof of concept applied 
approach 96 
3.4 Summary ................................................................................................................................. 103 
3.5 Future directions ..................................................................................................................... 104 
4 Conclusion ...................................................................................................................................... 105 





List of figures 
Figure 1: Bacteriophage lytic cycle 8 
Figure 2: Different types of cell wall structure 14 
Figure 3: Crystalline structure of D29 lysin B 17 
Figure 4: Phylogenetic tree of mycobacterium species 21 
Figure 5: Mycobacteriophage diversity 23 
Figure 6: Polyhydroxyalkanoate nanobead with endolysin proteins fused to surface 25 
Figure 7: Production of PHA nanobeads with fused endolysins 35 
Figure 8: Testing cell death induced by bead exposure by colony count 40 
Figure 9: Lab-made spray system 42 
Figure 10: Cladogram of a selection of lysin A mycobacteriophages (clusters labelled) 44 
Figure 11: Cladogram of a selection of lysin B mycobacteriophages from each cluster (clusters labelled)
 45 
Figure 12: Bacteriophage endolysin geographic location 50 
Figure 13: pET-14b endolysin fusion plasmid constructs 55 
Figure 14: Nile Red stain to detect presence of lipid nanobeads 58 
Figure 15: Purified nanobeads indicated by the white band in the glycerol gradient 58 
Figure 16: Contamination across increasing dilutions 60 
Figure 17: Gram stained contamination indicated Gram-negative bacterium present 60 
Figure 18: Endolysin nanobead size differences 62 
Figure 19: Scanning Electron Microscopy of three lysin nanobeads 63 
Figure 20: Phase contrast 100X microscopy of unstained lysin nanobeads 64 
Figure 21: Fluorescent microscopy of M. smegmatis exposed to nanobeads (1) 69 
Figure 22: Fluorescent microscopy of M. smegmatis exposed to nanobeads (2) 70 
Figure 23: Fluorescent microscopy of M. smegmatis exposed to nanobeads (3) 71 
Figure 24: Plate reader graphs of M. smegmatis cell states 73 
Figure 25: Endolysin nanobead controls in 96-well plate, no bacteria 74 
Figure 26: M. smegmatis after exposure to 10mg/ml endolysin nanobeads in the 96-well plate reader, 
shaking 75 
Figure 27: M. smegmatis cell death after 45 minutes exposure to 10mg/ml, 20mg/ml and 80mg/ml 
nanobead concentrations in a standing culture of at room temperature 80 
Figure 28: Giles is the most effective endolysin nanobead at 45 minutes 82 
Figure 29: M. smegmatis cell death after 5 hours exposure to 10mg/ml, 20mg/ml and 80mg/ml nanobead 
concentrations in standing culture at room temperature 84 
Figure 30: Inca is the most effective endolysin nanobead at 5 hours 86 
Figure 31: All endolysin combinations at each trial point 88 
Figure 32: Comparison of cell death with M. smegmatis WT and M. smegmatis colonies cultured from 
surviving colonies 91 
Figure 33: Surviving M. smegmatis colonies cultured and infected by Inca bacteriophage serial dilution 
3µl spot test 94 
Figure 34: 10µl of nanobeads on filter paper compared to a hospital mask 96 
Figure 35: M. smegmatis colonies stamped after exposure to nanobeads on filter paper 97 




List of tables 
Table 1: The lysin A and lysin B genes chosen for this project ................................................................ 32 
Table 2: Antibiotic concentrations ............................................................................................................ 33 
Table 3: Bacterial strains used in this work ............................................................................................... 33 
Table 4: NCBI BLASTp output ................................................................................................................ 47 
Table 5: Domain analysis of Lysin-like proteins by HHpred .................................................................... 52 
Table 6: Amount of nanobeads harvested ................................................................................................. 58 
Table 7: Endolysin nanobead mean bead sizes ......................................................................................... 61 
Table 8: Live/dead stain of M. smegmatis after exposure to nanobeads ................................................... 68 
Table 9: M. smegmatis average cell death and significance after 45 minutes of exposure to 10mg/ml, 
20mg/ml and 80mg/ml nanobead concentrations .............................................................................. 81 
Table 10: M. smegmatis average cell death and significance after 5 hours of exposure to 10mg/ml, 
20mg/ml and 80mg/ml nanobead concentrations .............................................................................. 85 
Table 11: Comparison of M. smegmatis colony morphologies between WT and endolysin nanobead-
surviving colonies .............................................................................................................................. 90 
Table 12: Raw colony counts of nanobead stamping experiment ............................................................. 98 
Table 13: Average cell death of M. smegmatis after being sprayed on nanobead-coated filter paper 
“masks” ............................................................................................................................................. 99 
vii 
 
List of abbreviations 
 
AMP    Ampicillin 
AMR    antimicrobial resistant 
ATCC    American Type Culture Collection 
BLAST   Basic Local Alignment Search Tool 
BLASTn   Basic Local Alignment Search Tool (nucleotides) 
BLASTp   Basic Local Alignment Search Tool (proteins) 
CB    Carbenicillin disodium salt 
CHX    Cycloheximide 
CM    Chloramphenicol 
CRISPR   Clustered Regularly Interspaced Palindromic Repeats 
E. coli    Escherichia coli 
FASTA   Fast Alignment Search Tool A 
IPTG    isopropyl β-D-1-thiogalactopyranoside 
HGT    horizontal gene transfer 
lysA    Lysin A 
lysB    Lysin B 
M. smegmatis   Mycobacterium smegmatis 
viii 
 
M. tuberculosis  Mycobacterium tuberculosis 
MAC    maximum accuracy algorithm 
MDR    multidrug-resistant 
MPI    Max Planck Institute 
MSA    multiple sequence alignment 
OD    optical density 
P011    passage 0 from frozen stock 
P1FF    passage 1 from frozen stock 
P2FF    passage 2 from frozen 
PBS    phosphate buffer solution 
PHA    polyhydroxyalkanoate    
PhagesDB   www.phagesdb.org 
SIE    superinfection exclusion systems 






For centuries bacterial pathogens have been an issue for human health by compromising 
physical health, economic stability and environmental prosperity. We are entering a new 
era of antibiotic consciousness, so it is important to be more aware of the current 
treatments to these pathogens and the sustainability of their effectiveness. The following 
introduction will establish the basis of mycobacterial impact as well as introducing the 
bacteriophage as a therapeutic alternative to antibiotics. We will then introduce this 
project in more depth, focussing on attaching mycobacteriophage endolysins to 
biodegradable nanobeads to test against Mycobacterium smegmatis. 
1.1 Bacterial infection of Mycobacterium species 
As at 2017, the Mycobacterium genus comprises of over 150 recognised species, with 
many environmental and pathogenic to humans and animals alike (King et al., 2017). This 
genus includes some well-known pathogens such as Mycobacterium tuberculosis, the 
causative bacterial pathogen responsible for infecting one third of the human population 
with tuberculosis (Sreevatsan et al., 1997). The World Health Organisation 2018 Global 
Tuberculosis report states that M. tuberculosis currently infects 1.7 billion people, causing 
1.3 million deaths in 2017 and further predicts that by 2050 there will be 10,000,000 
tuberculosis deaths in comparison to 8,200,000 deaths from cancer (WHO, 2018). When 
M. tuberculosis bacteria become active in the bloodstream, the human immune system 
cannot stop the bacteria from multiplying and this is what causes the disease (CDC, 2018). 
Lillebaek and colleagues state that out of the infected patients, only 10% of infected 
individuals appear to develop active disease which they have shown to activate 33 years 
past the first infection with the remaining 90% of cases remaining latent (M. tuberculosis 
bacteria is dormant and inactive with the possibility to be reactivated) (Lillebaek et al., 
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2002; Zumla, Raviglione, Hafner, & Fordham von Reyn, 2013). Latently infected 
individuals can still develop the disease, but it cannot be spread in latent form. 
 A 2016 report published by O’Neill estimates that by 2050, 10 million lives per year and 
a cumulative 100 trillion USD of economic output are at risk from the rise of drug 
resistant infections if solutions are not found now (O'Neill, 2016). 
1.1.1 Implications of untreated Mycobacterium in New Zealand  
The 2010 Ministry of Health report states that tuberculosis notification rates in New 
Zealand have been around 10 per 100,000 (0.01%) , decreasing to 0.007% in recent years 
(MoH, 2010). New Zealand has higher rates of M. tuberculosis than other developed 
countries (including 0.004% in the United States, 0.005% in Canada and 0.006% in 
Australia) and this may be attributed to immigration from countries with high incidence 
of M. tuberculosis and socioeconomic deprivation, with over two thirds of all cases in 
New Zealand from individuals born in a foreign country (MoH, 2010). More specifically, 
the highest rates of tuberculosis are seen in individuals occupying urban areas such as 
Auckland and South Auckland, along with individuals who are not of “European” decent 
(most notably Pacifica people and those who identify as “Other”) (MoH, 2010). However, 
from these reports of tuberculosis infection, New Zealand has comparatively low rates of 
resistance to antimicrobials used for treatment of tuberculosis (MoH, 2017). 
Other prominent members of the Mycobacterium genus include Mycobacterium 
smegmatis (the model organism for this research) and Mycobacterium bovis, the causative 
agent for zoonotic tuberculosis (Cosivi et al., 1998). The dairy industry is New Zealand’s 
largest export market worth in excess of $13.7 billion NZD and uncontrolled 
mycobacterial outbreaks have the potential to wreak havoc economically (Warren & 
Allen, 2017). Past studies have identified M. bovis present in swine and cattle populations 
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with the effect emphasised by the boom in possum population, however the strict 
regulations imposed by the New Zealand bovine tuberculosis control programme have 
reduced tuberculosis rates from 11% in mature cattle in 1905 to less than 0.003% in cattle 
in 2012/2013 (Livingstone, Hancox, Nugent, & de Lisle, 2015). 
1.1.2 Diagnosis and treatment of tuberculosis 
Tuberculosis is one of the most ancient diseases currently known to researchers, dating 
back 17,000 years (Sandhu, 2011). The unique intracellular location of the pathogen 
shields it from antibodies and airborne nature of M. tuberculosis can easily be spread from 
one infected host to the next (Kaufmann, 2001). The ease of spread and difficulty of 
diagnosis and treatment correlates with statistics suggesting 95% of developing nations 
are currently infected with tuberculosis, contributing to one third of the world’s current 
population latently infected (Oren, Bell, Garcia, Perez-Velez, & Gerald, 2017). 
Screening methods for the detection of tuberculosis include a field chest x-ray and culture 
along with the tuberculin skin test (TST) and the interferon- release assays (IGRA) 
which involve a blood test although it cannot determine the difference between latent and 
disease cases of tuberculosis (Linas, Wong, Freedberg, & Horsburgh, 2011; WHO, 2018). 
Some of the major difficulties in managing tuberculosis include the rigorous treatment, 
some toxicity in drugs used as well as the non-compliance of some patients, leading to 
complications in treatment success. First-line anti-tuberculosis drugs include isoniazid, 
rifampicin, pyrazinamide, ethambutol and streptomycin and fixed-dose combinations of 
these drugs are used to prevent drug resistance that could occur with separate drug 
treatments (WHO, 2010). Treatment of multi-drug resistant tuberculosis is more intensive 
with over 20 months of treatment resulting in a cost of $134,000 USD per case of MDR-
TB and $430,000 per XDR-TB (Suzanne et al., 2014). 
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1.2 Antibiotic resistant tuberculosis 
Not only do the effects of tuberculosis in the present-day concern human health, 
agricultural development and economic prosperity, they are also shaping the future of the 
world. In 2017, the World Health Organisation estimated that 558,000 people developed 
tuberculosis that was resistant to the most effective frontline drug rifampicin, a further 
82% of these reported cases were multi-drug resistant indicating they do not respond to 
at least rifampicin and isoniazid which are the two most powerful anti-tuberculosis drugs 
(WHO, 2018). Communities with those infected with HIV/AIDS are at further risk with 
the 2018 WHO report stating 464,633 tuberculosis cases among HIV-positive people 
were reported. It is therefore important for future treatments to take into consideration the 
current increasing rates of MDR tuberculosis, as well as the relationship to other diseases 
such as HIV.  
1.3 Transmission of tuberculosis 
Tuberculosis is an airborne pathogen, spread from person to person through the air 
through infected individuals coughing, sneezing or spitting (CDC, 2018; WHO, 2018). 
Living in a slum increases the risk of tuberculosis transmission due to over-crowding, air-
pollution and under-nutrition (WHO, 2018). Despite increasing access to treatment, 
WHO has estimated that over 3 million incidents of tuberculosis cases go undiagnosed 
and untreated every year, which perpetrates the continuous transmission (von Delft et al., 
2015). Even with a diagnosis, access to medication and treatment is often delayed, 
sometimes with a 2-month interval between symptom onset and the start of effective 
treatment (Salaniponi et al., 2000; von Delft et al., 2015). 
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1.3.1 Infection of health-care workers 
In 2017, 9,299 health-care workers from 65 countries were reported with tuberculosis, 
with the highest rate in Mozambique (WHO, 2018). The idea of increasing treatment 
coverage of tuberculosis to over 90% is one of the top 10 indicators for monitoring 
implementation of the End TB Strategy by WHO. The rationale for this is that high-quality 
tuberculosis care is essential to prevent suffering and death from the disease (WHO, 
2018). This report also states that current health interventions for TB prevention are the 
mitigation of tuberculosis transmission opportunities through prevention and control of 
infection. The most recent report addressing the risk for health care associated 
transmission of tuberculosis is the 2005 CDC report, stating that the transmission of 
tuberculosis to health care workers has been linked to close contact with tuberculosis-
infected patients during aerosol-generating or aerosol-producing procedures (CDC, 
2005). An updated administrative refocus on “Finding (patient) cases Actively, Separate 
temporarily and Treat effectively (FAST)” has been advocated despite the difficulty of 
applying all of these measures in low resource, high tuberculosis settings where most 
occupational (health-care workers are effected) tuberculosis cases occur (Ehrlich, 2018). 
This has resulted in health care workers calling for advocacy and pressure from the 
government to take the need for preventative transmission seriously (Ehrlich, 2018). 
Because these health care workers are not always adequately protected, we want to take 
advantage of the antimicrobial lysis properties of bacteriophage and use these as a 
prophylactic prevention method as a barrier aid to minimise the risk of aerosol-generated 
tuberculosis pathogens on objects where the bacteria can interact with the lytic 
mechanism, including hospital masks and bench surfaces. This research focusses on the 
use of lytic enzymes from bacteriophages fused to polyhydroxyalkanoate nanobeads as a 
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proposed prophylactic treatment to individuals at risk of infection including health care 
workers in the field, discussed further at the end of this section. 
The infection does not end with the health-care worker alone. Those infected can further 
transmit tuberculosis to their families and those around them, which is why it is important 
to protect and target this mycobacterial pathogen at the front line. An example from a 
study by Sterling and colleagues, reported the first documented tuberculosis transmission 
from a cadaver with partially treated tuberculosis to an embalmer who had previously 
been tested to not have tuberculosis. The study concluded that aerolisation from the 
airway from the airway of the cadaver to the embalmer was the mode of tuberculosis 
transmission and this aerolisation remains a risk to our health care workers today (Daniel, 
2001; Sterling et al., 2000).  
It is important to realise that the effects of tuberculosis infections of healthcare workers 
extend to their family beyond physical implications, including risk of transmission to 
loved ones, financial hardship, community stigma and career limitations, with von Delft 
and colleagues stating one physician called her husband weeping “I could die”, as she 
threw up blood in her basin sink a few weeks before being diagnosed with extreme drug-
resistant tuberculosis (von Delft et al., 2015). Daniel and colleagues state that it is difficult 
to generalise the magnitude of occupational tuberculosis risk for non-hospital workers, 
however they acknowledge the idea that ventilation, recognition of tuberculosis cases and 
isolation procedures may be less than ideal in non-hospital settings (Daniel, 2001). This 
correlates with the statistics that state 95% of tuberculosis cases occur in developing 
nations where one third of the world’s population is latently infected (Daniel, 2001; Oren 
et al., 2017). It is therefore crucial to have correct protection measures and alternatives to 
antibiotic treatment in place in order to prevent the unnecessary spread of tuberculosis 




Bacteriophages were first noticed through “glassy and transparent” zones of dead bacteria 
by English physician, Frederick Twort, in 1915 (Keen, 2015). They are viruses that only 
infect bacteria and occupy a profound role in environmental and biological processes with 
over 1031 phage particles – the most abundant living entity on Earth (Comeau et al., 2008; 
Keen, 2015). Bacteriophages have a large environmental impact and can infect between 
15% - 40% of the ocean’s bacterial population each day which can thereby influence 
dissolved carbon ratios through to phytoplankton productivity (Danovaro et al., 2011). 
However, it is their unique host specificity which gives them an advantage over more 
broad range antibiotics in healthcare, with lytic bacteriophages (that kill bacteria as 
opposed to lysogenic bacteriophage that integrate into the host bacterium’s DNA) having 
considerable therapeutic potential (d'Herelle, 1931; Keen, 2015). There have been 
numerous studies that use bacteriophage as antimicrobials in health care, agriculture and 
food production that will be discussed in more depth throughout this section. 
1.4.1 Bacteriophage life cycle  
Bacteriophages are viral parasites that bind to the cell surface of a specific bacteria, inject 
in their genetic material and take advantage of the hosts cellular machinery needed to 
replicate, prior to bursting out of the cell through a lysis event, causing bacterial death 
shown in Fig. 1 (Kingwell, 2015). Some bacteriophage carry out a lysogenic life cycle, 
wherein they inject their DNA into the bacterial chromosome, however these types of 
bacteriophage are less desirable from an antimicrobial phage therapy option, as they can 
spread virulence factors or antimicrobial resistance throughout the bacterial host (Higgins 
et al., 2005; Kingwell, 2015). 
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1.4.1.1 Lysis from without 
“Lysis from without” or exogenous lysis refers to the lysis event as a result of 
extracellularly applied lysis agents (such as endolysins) (Abedon, 2011). An earlier 
definition defines the external lysis phenomenon as “abortive infection accompanied by 
prompt lysis of a cell, typically following excessive multiple infection” (Schuster, 1962). 
Nevertheless, throughout this thesis the simplified idea of lysis from without will refer to 
the exposure of bacterial cells to endolysins fused to biodegradable nanobeads and the 
subsequent effect these will have. 
1.4.2 Bacterial resistance to bacteriophages 
Bacteriophages are strong drivers of bacterial evolution as bacteria are constantly 
evolving to evade their viral predators (Chibani-Chennoufi, Bruttin, Dillmann, & 
Brüssow, 2004). Because we are interested in developing methods of infecting and killing 
the bacteria that do not have a large suite of resistance mechanisms to counteract the lytic 
Figure 1: Bacteriophage lytic cycle. 
Bacteriophage bind to specific receptors on the bacterial cell wall and inject their DNA. The lytic cycle 
demonstrates how bacteriophage replicate within the cell before bursting through the cell wall, rupturing 
the bacteria and releasing new viruses. Adapted from (Kingwell, 2015). 
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process, it is useful to understand the processes behind bacterial lysis and the resistance 
mechanisms at each existing step. 
Work by Hofnung and colleagues suggest bacterial resistance can involve mutations that 
result in a change in structure, or even the entire loss, of the bacteriophage binding site 
through deletion mutations (Hofnung, Jezierska, & Braun-Breton, 1976). Although the 
Hofnung study focussed on E. coli K12 λ bacteriophage, we will explore these 
mechanisms in relation to mycobacteria. Because of these conclusions, we are looking 
into a way of avoiding these resistance strategies highlighted below, using the framework 
of the lytic infection cycle (Fig. 1) in order to lyse the bacterial cell prior to resistance.  
Throughout evolution, bacteria have evolved resistance methods to counteract the impact 
of the bacteriophages that target various steps within the bacteriophage life cycle, 
specifically blocking adsorption, preventing DNA injection, rejecting the incoming DNA 
and abortive infection systems (Chibani-Chennoufi et al., 2004; Sturino & Klaenhammer, 
2006). Because this work focusses on the possibility of using mycobacteriophage-derived 
proteins for mycobacterium cell lysis, we will also describe what is known of 
mycobacteriophage-specific resistance in each instance, although often their 
contributions to mycobacteriophage host preferences are poorly understood (Jacobs-Sera 
et al., 2012).  
1.4.2.1 Bacteriophage attachment prevention 
Bacterial strains have evolved to prevent bacteriophage adsorption to cell receptors 
through three key strategies; receptor blocking (using bacteria-specific proteins), 
extracellular matrix production and competitive inhibitor production (Labrie, Samson, & 
Moineau, 2010). Bacteriophages initiate infection by attaching and binding to specific 
receptors upon the surface of their host bacteria, before inserting their DNA (J. Chen et 
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al., 2009). Bacteria can also produce extracellular polymers (hydrolases and lyases) that 
can protect the bacteria from its environment as well as providing a physical barrier 
between the bacteriophage and their receptors (Labrie et al., 2010). Although some 
bacteriophage are able to recognise these polymers with the potential to even degrade 
them, the means of bacteriophage attachment to the cell wall are limited, especially in 
regards to mycobacterial infections (McNerney & Traoré, 2005; Stummeyer et al., 2006). 
However, there have been multiple studies looking into the relationship between specific 
mycobacteriophage D29 and cell wall receptors. Hatfull suggests that the loss of cell wall 
receptor in mycobacteria does not prevent D29 from attaching, thereby not conferring 
resistance, however an earlier study with colleague Barsom showed that an M. smegmatis 
mutation with an insertion upstream of the mpr gene, when the mpr gene was 
overexpressed, resistance to D29 occurred (Barsom & Hatfull, 1996; Hatfull, 2014; 
McNerney & Traoré, 2005). The resistance occurs by inhibiting the transport of 
bacteriophage DNA across the cell wall (McNerney & Traoré, 2005). 
1.4.2.2 Bacteriophage entry prohibition 
Superinfection exclusion systems (SIE) are proteins that block bacteriophage entry into 
potential bacterial host cells and are predicted to be anchored or strongly associated with 
membrane components (Labrie et al., 2010). In other words, SIE occurs when infection 
by an existing bacteriophage prevents and secondary infection by that bacteriophage or 
another closely related virus. Hopkins and Ptashne describe a potential mechanism to 
superinfection exclusion through a prophage, where bacterial “escape” is infrequent 
(Hopkins & Ptashne, 1971). The 1971 study further explains that at least three mutations 
would be required in order to confer the virulent phenotype (Hopkins & Ptashne, 1971; 
Jacobs-Sera et al., 2012). Jacobs-Sera and colleagues state that SIE in mycobacteria are 
still poorly understood. 
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1.4.2.3 Bacteriophage nucleic acid modifications 
Bacteria have modification systems that cleave bacteriophage genomic DNA (site 
specific sequences if they do not carry methylation marks specific to the system) and 
these systems can be classified into at least four groups, type I – IV (Labrie et al., 2010). 
When unmethylated bacteriophage DNA enters into a bacterial cell which carries out one 
of these nucleic acid modification systems, it is immediately recognised and cleaved by 
a specific restriction enzyme to be degraded or at the least methylated to ensure the 
bacteriophage lytic cycle is not initiated (Kruger & Bickle, 1983). Bacteriophage have 
developed defense to this system by modifying their genomes to avoid DNA cleavage, 
by incorporating unusual bases in their systems, such as Bacillus subtilis bacteriophages 
that replaces thymine with 5-hydroxymethyluracil (Hopkins & Ptashne, 1971; Jacobs-
Sera et al., 2012). Bacteriophage can also defend themselves by employing “palindromic 
avoidance” through avoiding palindromic repeats in their genetic sequences, as type II 
bacterial restriction endonucleases can often recognise these palindromic repeats (Rocha, 
Danchin, & Viari, 2001; Stern & Sorek, 2011). In the case of mycobacterium, there have 
been five restriction modification systems identified in five closely related 
mycobacterium (Roberts & Macelis, 2001; Rocha et al., 2001). Although there are few 
examples of mycobacterium employing these systems to evade bacteriophage infection 
nevertheless this is a prime example of the ongoing coevolution between bacteria and 
bacteriophages. 
1.4.2.4 CRISPR Cas systems 
Clustered regularly interspaced palindromic repeats (CRISPR) and the associated Cas 
genes are another effective mechanism becoming more prominent in evolution 
throughout the bacterial kingdom for reducing the infection by bacteriophages (Godde & 
Bickerton, 2006). CRISPR is an immunity system that targets foreign nucleic acids 
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including those of bacteriophage genomes and plasmids by taking up genetic material 
from invasive elements such as bacteriophage and building up an inheritable DNA-
encoded immunity over time (Marraffini & Sontheimer, 2008). The CRISPR systems 
works by having loci which typically consist of several non-contiguous direct repeats 
separated by stretches of variable sequences call spacers that correspond to segments of 
captured bacteriophage sequences, often adjacent to associated Cas genes (Horvath & 
Barrangou, 2010). In turn, these Cas genes encode a large and heterogeneous family of 
proteins carrying the functional domains that are typical of nucleases, helicases, 
polymerases and polynucleotide-binding proteins which allow the bacterial cell to cleave 
the recognised bacteriophage DNA upon initial entry into the bacterial cell (Haft, 
Selengut, Mongodin, & Nelson, 2005; Horvath & Barrangou, 2010). 
The constant exposure to exogenous DNA as a result of transduction, conjugation, and 
transformation have forced over 90% of bacterial species to establish an array of defense 
mechanisms (Horvath & Barrangou, 2010). Although there is limited knowledge around 
M. smegmatis mc2155, He and colleagues state that there CRISPR Cas systems active 
against mycobacteriophages can be found throughout 14 mycobacteria  (He, Fan, & Xie, 
2012; Jacobs-Sera et al., 2012; Liu et al., 2014; Samaddar et al., 2015). Choudhary and 
colleagues also note that specifically there are no type II CRISPR Cas systems in 
mycobacterium, not ruling out the presence of other CRISPR type systems (Choudhary, 
Thakur, Pareek, & Agarwal, 2015). 
Some bacteriophages can defend against CRISPR Cas systems by employing anti-
CRISPR proteins, however this does not always provide immunity against the CRISPR 
Cas system and the success depends on how many bacteriophages are present for 
infection. In bacteriophages that do have this defense mechanism, the first bacteriophage 
to infect a CRISPR-encoded bacterium will most likely be destroyed by the CRISPR Cas 
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system before it is able to make enough anti-CRISPR proteins, nevertheless the anti-
CRISPR proteins that it does make will still persist in the bacterial cell that will help to 
supress it’s defense systems. Therefore, the next bacteriophages that come along will help 
to contribute to the eventual overturn of CRISPR with an influx of anti-CRISPR proteins 
that will take down the immune system and render the bacterial cell viable for infection. 
It can be thought of as a sacrificial cooperative effect, with the bacteriophage that are the 
slowest to infect having the greatest chance of a full lytic cycle. 
We are interested in developing methods to infect bacteria where they do not have 
resistance mechanisms to counteract the bacteriophage. In the last step of the lytic cycle 
shown in Fig. 1, bacteriophage use a programmed timed response from the holin protein 
enabling the access of endolytic enzymes to make contact and cleave the peptidoglycan 
cell wall. By taking advantage of the endolysin proteins that operate in the final stage of 
the lytic cycle whereby bacteria can no longer establish resistance mechanisms, we can 
initiate lysis “from without” at the very beginning enabling us to overcome the resistance 
mechanisms aforementioned. 
1.5 Gram-positive cell walls 
Gram-positive bacterial species differentiate from their Gram-negative counterparts in 
that they lack an outer membrane yet compensate with a thicker cell wall, in comparison 
to Gram-negative bacteria which have an outer membrane present as shown in Fig. 2 
below. The cell walls of mycobacteria (a Gram-positive organism) are composed of thin 
layers of peptidoglycan and arabinogalactan with a thick wall of mycolic acids which is 
unique to mycobacteria compared to other Gram-positive bacteria (Fig. 2) (Brennan; Lisa 
Brown, Julie M. Wolf, Rafael Prados-Rosales, & Arturo Casadevall, 2015). Therefore, it 
is important when identifying protein candidates, to select candidates that are capable of 
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cleaving through both the peptidoglycan component of the cell wall, in addition to the 
thick wall of mycolic acids present. 
While mycobacterium species are Gram-positive bacteria that lack a traditional outer 
membrane and contain a relatively thick layer of PG, they also have a unique outer 
membrane structure that is analogous to the outer membrane of Gram-negative species 
(K. M. Payne, 2006). The cross-linked design of the bacterial cell wall is responsible for 
keeping the cell at a high internal pressure of between 15-25 atmospheres and therefore 
any damage or disruption to this cell wall can result in extrusion of the cell membrane to 
the outer environment and hypotonic lysis (Fischetti, 2010a). In natural systems, 
bacteriophage lyse from within to release bacteriophage progeny and as a result require a 
long tail protein to allow access to the cell membrane and consequently the cytoplasm. 
1.6 Endolysins 
Endolysins are enzymes produced by bacteriophage with the purpose of attacking one of 
the four major bonds in the peptidoglycan component, digesting the bacterial cell wall to 
Figure 2: Different types of cell wall structure 
A) Gram-negative cell wall with distinctive outer membrane, B) Gram-positive cell wall with lack of outer 
membrane and no mycolic acid layer, C) Mycobacterial cell wall displaying thick mycolic acid layer in 
addition to the peptidoglycan cell wall. The most significant difference between the Gram-negative and 
Gram-positive cell walls is that the Gram-negative cell wall has an outer membrane meaning bacteriophage 
attachment differs from Gram-positive bacteriophages. Adapted from (L. Brown, J. M. Wolf, R. Prados-
Rosales, & A. Casadevall, 2015).
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initiate bacteriophage progeny release (Fischetti, 2010a). In natural systems, 
bacteriophages do not have signal sequences (so they are not translocated through the 
cytoplasmic membrane), instead this function is controlled by another protein called holin 
(I. N. Wang, Smith, & Young, 2000). The endolysin accumulates into a fully-folded, 
active state in the cytoplasm, waiting for the small membrane holin protein to allow the 
endolysin access through the membrane due to a timing process “programmed” in to the 
holin itself (I. N. Wang et al., 2000). Once the endolysin makes contact with the cell wall, 
this lysis results in destruction of the cell and the bacterium’s ability to survive. In the 
past, studies have focussed on using the whole bacteriophage to exploit the bacterial cell, 
however only recent endeavours have focussed primarily on lytic enzymes in isolation of 
the whole virus (Fischetti, 2010a; Loeffler, Djurkovic, & Fischetti, 2003; Nelson, 
Loomis, & Fischetti, 2001; Schuch, Nelson, & Fischetti, 2002). These studies, 
specifically using mycobacteriophage D29, will be discussed further throughout this 
thesis. 
Because bacteria have evolved resistance over time to bacteriophages, in the forms of 
attachment prevention, entry prohibition, nucleic acid modifications and CRISPR Cas, it 
is important to identify methods of cell lysis to lyse the cell before these mechanisms can 
initiate. Phage endolysins are both enzymatically and architecturally diverse with a large 
variation in both length and size. There are 24 enzymatic catalytic domains and 13 cell 
binding domains in bacteriophage endolysins (Oliveira et al., 2013). Lytic enzymes such 
as endolysins are suitable lysing agents as they are able to make direct contact with the 
cell wall carbohydrates and peptidoglycan when they are applied externally “from 




In the case of Gram-positive Streptococcus pneumoniae bacteria, 2,000g of the Cpl-1 
pneumonococcal bacteriophage lysin was able to kill S. pneumoniae within 15 minutes, 
reducing it from a median of log10 4.70cfu/ml to undetectable levels (Loeffler et al., 
2003). In natural systems, once the holin protein has made the hole in the cell membrane, 
it takes only seconds for the endolysin to lyse through, releasing the bacteriophage 
particles into the environment (Gründling, Manson, & Young, 2001; I.-N. Wang, 2006). 
Gram-positive cell endolysins exhibit a two domain structure with the N-terminal domain 
retaining peptidoglycan-hydrolysing activity to cleave one of the four major bonds in the 
peptidoglycan (highly conserved domain) whilst the C-terminal cell binding domain 
(connected via a short linker) binds to a substrate in the host cell wall (which is usually a 
carbohydrate but can vary) (Fischetti, 2008; Schmelcher, Donovan, & Loessner, 2012). 
Although the lytic domain of the endolysin that allows it to cleave through the 
peptidoglycan call wall can be active on a variety of different bacteria, endolysins can 
still be extremely specific, often down to a specific serovar of host specie through the 
specificity of the cell wall binding domain components.  
1.6.1 D29 mycobacteriophage lysin B demonstrates cell lysis from without 
Previous studies have shown that mycobacteriophage D29, crystalline structure shown in 
Fig. 3 below, has the capability to lyse M. smegmatis exogenously through an interaction 
between catalytic and cell wall binding domains (Pohane, Patidar, & Jain, 2015). Work 
by Payne in 2006, shows a decrease in cell accumulation by adding D29 lysin to a fresh 
culture of Mycobacterium smegmatis which resulted in some growth inhibition through 
biofilm degradation (K. M. Payne, 2006). The external lipid-rich cell wall structure of M. 
smegmatis is more likely to contain substrates for lysis through the lysin B protein, which 
is why there is more evidence supporting lysin B over lysin A (Ojha, Trivelli, Guerardel, 
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Kremer, & Hatfull, 2010).  Through extensive research into D29 lysin B, the crystalline 
structure has suggested close similarity to other α/β hydrolase cutinases including 
esterases and lipases. 
For bacterial cells to evade exogenous lysis “from without”, there would need to be a 
series of mutations in the mycolic acids and peptidoglycan components of the cell wall to 
prevent the lytic cleavage of these cell wall domains by the endolysins. This would require 
a significant genetic re-structuring of the cell wall, potentially compromising other 
important bacterial mechanisms, making this resistance opportunity extremely unlikely. 
This is one of the advantages for utilising an external lytic antimicrobial. The current 
differences in cell wall composition between Gram-negative and Gram-positive species 
already presents a boundary for increased host-range for bacteriophage, with most 
bacteriophage only being able to infect a narrow host range. 
This D29 lysin B protein sequence is available on the publicly accessible PhagesDB.org 
and will be used as the positive control throughout this research. 
Figure 3: Crystalline structure of D29 lysin B 
A) The biological assembly of the secondary structure of the D29 lysin protein. B) A magnified view at the 
catalytic triad of Ser82, His240 and Asp166 that occupy a similar position to other members of the α/β 




1.6.2 Endolysin diversity 
There is incredible diversity within mycobacteriophage endolysins, with enormous 
variation and up to a two-fold difference in size. More specifically, around 90% of 
endolysins have three conserved domains unlike other bacteriophage endolysins that only 
have two domains (K. M. Payne & Hatfull, 2012). These domains include; C-terminal 
domain which functionally corresponds to the C-terminal cell wall binding domain, 
allowing the endolysin to carry out peptidoglycan hydrolase (cleaving the peptidoglycan 
bonds in the cell wall), a centrally located amidase, muramidase or transglycosylase, and 
the N-terminal whose function is not as well understood but appears to encode a series of 
peptidases (K. M. Payne & Hatfull, 2012). Payne and Hatfull also explain that there are 
over 120 possible combinations of endolysins with six possible types of N-terminal 
domains, five types of amidase/glycosidase domains and a further four putative C-
terminal cell wall binding motifs. This extraordinary diversity results in cell wall 
specificity when binding (K. M. Payne & Hatfull, 2012).  
1.6.3 Advantages of endolysins 
Using endolysins to lyse exogenously bypasses the possibility of initiating resistance 
mechanisms from the bacterial cell. As aforementioned, the bacterial host cell has a 
number of ways to defend itself against the infection of foreign matter. By using an 
exogenous application of endolysins independent of the bacteriophage lytic cycle, we are 
able to bypass this system and attack the peptidoglycan cell wall on the bacterial cell in 
order to signal lysis. In natural systems endolysins interact with the smaller holin 
molecule, however the endolysins themselves are the molecules that are the direct cause 
of lysis which requires fewer programmed pathways when using endolysins exogenously. 
Another advantage of Gram-positive-specific endolysins is that the exogenous nature of 
the cell wall enables the endolysins to be able to make direct contact with the 
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carbohydrates and peptidoglycan components as a potential proof-of-concept 
antimicrobial against pathogenic mycobacteria (Fischetti, 2010b). Because of the 
specificity required to lyse the cell wall components, endolysins provide no threat to 
internal microflora nor eukaryote cells if applied in vivo. Endolysins are fast acting, with 
studies suggesting they can infect and kill Gram-positive bacteria after seconds of contact 
which is further evidence towards the applied practicality of this research project 
(Loeffler, Nelson, & Fischetti, 2001; Nelson et al., 2001). 
Lysins have also been demonstrated to be safe to use for humans and other eukaryotes as 
the murein hydrolases that are active domains of lysins, target the peptidoglycan cell wall 
that is only present in bacteria (Sharma, Vipra, & Channabasappa, 2018). A 2012 study 
from George and colleagues demonstrated that lysin P128 was completely inactive on 
eukaryotic cells, with no toxicity reported on cell lines Vero and HEp2 at the highest 
concentrations of 2.5mg/ml (George et al., 2012). Another Phase I clinical trial from Jun 
and colleagues in 2017 using lysin Sal-200 did not show any serious adverse effects on 
eukaryotic cells when tested using concentrations of 10mg/kg on healthy human male 
volunteers (Jun et al., 2017). Because the ultimate goal for this project is to develop a 
prophylactic tool to prevent mycobacteriophage infection, it is important to know the 
effects of lysins on human health. 
1.6.4 Complications associated with endolysins 
As previously mentioned, the endolysin requires the pre-programmed timing of the holin 
in order to initiate cell lysis through creating a hole in the cell membrane in natural 
systems. This can be a challenge when the endolysin is required to act as the sole lysing 
agent without the holin present as the lack of signal sequences prohibit the endolysin from 
its lysis ability. However, this can work as an advantage when applied externally, relying 
on environmental pressure to permeate the cell membrane after cell wall damage. A major 
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disadvantage compared to whole bacteriophage therapy, is the absence of self-replication 
by the endolysin proteins, unlike bacteriophage that self-replicate within the host cell 
(O'Flaherty, Ross, & Coffey, 2009). Another complication is the resistance mechanisms 
that the bacterial cell has evolved to counteract the bacteriophages lytic infections. There 
is an opportunity for bacteria to develop resistance to this exogenous lysis agent; however, 
this would require an almost complete reformation of the peptidoglycan and mycolic acid 
components of the cell wall which is improbable at this stage. 
1.7 Mycobacterium smegmatis mc2155 as a model organism 
Unlike most pathogenic bacteria that are slow-growing and harmful, M. smegmatis is fast-
growing and non-pathogenic as well as being closely related to pathogenic bacteria M. 
tuberculosis and M. bovis as illustrated below in Fig. 4 (Snapper, Melton, Mustafa, 
Kieser, & Jr, 1990; Vishnoi et al., 2010). 
Contrary to the cell wall structure of most Gram-positive bacteria, M. smegmatis has an 
additional lipid layer, similar to M. tuberculosis, observed in Fig. 2 (Jayawardana et al., 
2015). In addition, there is a large, publicly accessible database where over 1,600 M. 
smegmatis bacteriophage genome sequences are stored, detailed below (Russell & 
Hatfull, 2017). This database enables the access of lysin candidates from bacteriophage 
discovered throughout the world. 
M. smegmatis also has evidence of mycobacteriophage D29 having lysed the cell 
exogenously resulting in observable cell death. Because of these qualities, M. smegmatis 
was selected as the model organism for this project.   
21 
1.8 PhagesDB.org 
Phagesdb.org (PhagesDB) is a comprehensive and interactive Actinobacteriophage 
website that provides open-access information related to the discovery, characterisation, 
and genomics of bacteriophage that infect Actinobacterial hosts, including both M. 
smegmatis and M. tuberculosis (Russell & Hatfull, 2017). As at February 2019, 
PhagesDB contained 15,059 bacteriophages uploaded, 10,416 of which infect 
Mycobacterium species and 1,729 of which are sequenced. PhagesDB accepts 
bacteriophage isolations from different countries throughout the world, encompassing 
both hemispheres and a range of environments resulting in a diverse array of 
bacteriophage genomes and characterisation present. When bacteriophages are genome-
sequenced and annotated, the information becomes available down to the annotation of 
Figure 4: Phylogenetic tree of mycobacterium species 
Based on 16S rRNA, this phylogenetic tree indicates that M. smegmatis is the most closely-related yet non-
pathogenic bacterial species to M. tuberculosis which makes it a suitable bacterium to use for this project 
(Vishnoi, Roy, Prasad, & Bhattacharya, 2010). 
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each specific gene, resulting in a detailed resource available. Because of this layout, 
PhagesDB is a significant preliminary measure to identify the location of endolysins 
within mycobacteriophage. To date, there has been one published article discussing a 
mycobacteriophage isolated from New Zealand, StepMih (Butela et al., 2017). 
Bacteriophages are added to the database through high school, college and undergraduate 
“phage hunting” programmes which means an extra series of bioinformatic tests will be 
carried out in this research to provide further evidence that the lytic enzymes selected are 




Figure 5: Mycobacteriophage diversity 
A) 2015 literature illustrates the diversity of gene content relationships through 627 sequenced 
mycobacteriophages displayed as a network phylogeny. The multiple branches reflect the phylogenetic 
complexities as a result of the mosaic bacteriophage genomes where many genes within the genome have
a distinct evolutionary history (Pope et al., 2015). B) Mycobacteriophage also have diverse isolation




1.9 Mycobacteriophage clusters 
One of the useful features of PhagesDB is the display of bacteriophage clusters. It has 
been proposed that two mycobacteriophage genomes that display over 50% nucleotide 
sequence similarity should be grouped into the same cluster, with some clusters 
containing bacteriophage with over 90% nucleotide sequence similarity such as 
mycobacteriophage Bxz1 and Catera (Fig. 5) (Hatfull, Cresawn, & Hendrix, 2008; Sassi, 
Bebeacua, Drancourt, & Cambillau, 2013). Currently on PhagesDB there are 29 known 
mycobacteriophage clusters (including a Singleton cluster for bacteriophage that do not 
fit into any existing cluster), with 56 sub clusters. Although the research from Hatfull and 
colleagues suggests inclusion of mycobacteriophage genomes within clusters is largely 
on an “ad hoc” basis, rather than with strict criteria, this research aimed to identify 
endolysin candidates capable of exogenous mycobacterium lysis from a range of 
bacteriophages therefore this initial cluster identification and assortment is a tool to begin 
exploration with. 
 
1.10     Biodegradable nanobeads 
Polyhydroxyalkanoates (PHA) are the largest group of natural biopolymers, produced in 
various microorganisms as carbon and energy reserves when the main growth nutrient is 
limited (Kamravamanesh, Lackner, & Herwig, 2018; Li, Yang, & Loh, 2016). These 
PHAs consist of hydroxyalkanoic acids linked by oxoester bonds with an amorphous 
polyester core surrounded by a boundary layer of embedded or attached proteins (Fig. 6), 
including PHA synthase (PhaC) which can be N-terminally fused to a protein of interest, 
and can range in size from 100nm – 500nm (K. Grage et al., 2009; Rehm, 2003). PHAs 
have been developed for use in biomedical and industrial applications and have been 
shown to be well tolerated by mammalian systems (Katrin Grage et al., 2009) . There has 
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also been research in to using E. coli strains, including BL21, to produce PHA nanobeads 
with the overexpression of the corresponding plasmids which is the basis of this study 
(Blatchford, Scott, French, & Rehm, 2012).  
These PHA nanobeads are water insoluble (although still biodegradable). Because PHA 
nanobeads are carbon reserves, they are naturally degraded by PHA depolymerase (PhaZ) 
during times of carbon starvation (Chek et al., 2017). PHA nanobeads offer two distinct 
advantages as proteins of interest are covalently bound in a uniform direction to the 
surface and these can be expressed through a one-step process (Lee, Parlane, Rehm, 
Buddle, & Heiser, 2017).  
 
1.10.1 PHA biodegradability 
A unique aspect of PHA nanobeads is their complete biodegradability. In various 
environmental conditions (including soil, sea water, lake water and anaerobic sludge), 
bacteria including Acidovorax facilis, Aspergillus fumigatus, Comamonas sp., 
Pseudomonas lemoignei, Pseudomonas fluorescens, Comamonas testosterone and 
Polyester core 
Endolysin N-terminally 
fused to PhaC 
PhaC 
Figure 6: Polyhydroxyalkanoate nanobead with endolysin proteins fused to surface 
Each PHA nanobead has only one type of lysin fused to the surface (either lysin A or lysin B). This is a 




Ilyobacter delafieldii excrete extracellular PHA depolymerases which degrade the PHA 
molecules into water soluble monomers and oligomers to be reused as a carbon source 
(Anderson & Dawes, 1990). However, the rate of biodegradation is dependent on several 
factors including the microbial population present, pH and the temperature (Mergaert, 
Anderson, Wouters, Swings, & Kersters, 1992). Due to the changing landscape, studies 
surrounding the commercial viability of PHA are underway, exploring these 
biodegradable nanobeads as an antimicrobial drug delivery alternative in the biomedical 
field. Anticipation for commercial PHA use include high-end products with distinct 
properties and a definite purpose of utilisation where the PHA biocomplexity and 
biodegradability would aid as an advantage, such as drug delivery materials, tissue 
engineering and nanobiotechnology yet PHA’s can also be utilised for low-end products 
where the biodegradability is an advantage but the main benefit would be the economic 
efficiency, such as organic waste bags, single use packaging and toys (Kovalcik, Obruca, 
Fritz, & Marova, 2019). 
1.10.2 PHA synthase 
PHA synthases catalyse the polymerisation of PHA polymers as the key enzyme in PHA 
synthesis. PhaC is the key enzyme involved in the biosynthesis of PHA and polymerises 
monomeric hydroxyalkanoate substrates (Chek et al., 2017). There are currently four 
reported classes of PHA synthase, including; Class I which forms a homodimer, Class II 
which contains synthases PhaCI and PhaCII, and Class III and IV synthases that form 
heterodimers and favour short chain length monomers (Chek et al., 2017). The subunit 
size of Class I and II have a subunit size of approximately 60 to 70kDa whereas the 
subunit size of Class III and IV are larger having two subunits (Jendrossek, 2009; Rehm, 
2007). All PHA synthases share a conserved cysteine as a catalytic site and this is where 
the PHA chain is covalently attached (Jendrossek, 2009). Early evidence suggests that 
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activity from PHA synthase is directly associated with isolated PHA granules (Griebel & 
Merrick, 1971). 
Phasins are PHA granule-associated proteins that promote bacterial growth and can 
influence the size, number and distribution of these granules (Mezzina & Pettinari, 2016). 
Phasins also amphiphilic proteins which shield the inner hydrophobic polymer from the 
cytoplasm of the cell (Maestro & Sanz, 2017). Pӧtter and colleagues suggest phasin 
homologue PhaP1 constitutes the major component of the layer at the surface of poly(3-
hydroxybutyrate) granules (Pötter et al., 2004).  
 
1.11     Aims 
The aims of this thesis can be separated into three parts: (1) the bioinformatic 
identification of candidate mycobacteriophage endolysins capable of lysing exogenously, 
(2) the design and development of unique biodegradable nanobeads equipped with 
endolysins fused on the surface and (3) to test the capacity of these endolysin proteins 
delivered on biodegradable nanobeads to kill M. smegmatis cells through a series of 
quantifiable tests.  
Aim 1: Choose endolysins to lyse exogenously 
The objectives related to this aim revolve around using bioinformatics tools to identify 
appropriate endolysins using the PhagesDB database. Though D29 is a mycobacterial 
endolysin that is known to function in this way, this does not give us a screening method, 
other than to focus our attentions on lysin B homologues. I will use software-based 
approaches to ensure that the genes chosen for cloning have domains associated with 
lysis. I set out to choose two lysin A proteins and six lysin B proteins. I will then use the 
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available genome data from over 1,600 sequenced mycobacteriophage accessed from 
PhagesDB to, select candidates across a range of clusters. The first aim will be wrapped 
up with the comparisons of the selected candidates to increase accuracy of lysin candidate 
selection using NCBI BLAST, Clustal Omega and HHpred. 
Aim 2: Design and develop unique biodegradable nanobeads 
The objectives required to support this aim are based on using the selected candidates to 
go through a series of in vitro processes to produce a functioning and applicable 
biodegradable nanobead in order to transport these lysis candidates to infect the bacterial 
cell through surface fusion. This specific objectives for this aim were to work in 
conjunction with GeneArt and AgResearch to design and synthesize N-terminal fusion 
construct plasmids. Collaborate with the AgResearch Grasslands team to electroporate 
the synthesized plasmids into E. coli, express the PHA nanobeads in E. coli and harvest 
and purify the nanobeads to be used in in vitro experiments whilst also being able to 
construct these nanobeads at Massey University too. 
Aim 3: Test endolysin nanobeads on M. smegmatis to see cell death 
The objectives for this aim are to design and implement methods for testing the 
antimicrobial lytic activity of the endolysin nanobeads against M. smegmatis. A series of 
quantitative and statistically sound tests were devised to test the effectiveness of the beads 
produced, including live/dead microscopy to observe the degree to which whole cells 
appeared damaged but not completely lysed, a plate reader experiment to understand how 
the nanobeads lyse in shaking conditions, testing the nanobeads using colony forming 
unit assays to observe M. smegmatis cell death through a colony decrease after exposure 
in a standing culture and finally a nanobead test on filters or hospital masks to demonstrate 
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the degree to which they could serve as a prophylactic barrier against infection of M. 
tuberculosis in practical medical settings as a proof-of-concept. 
1.12     Summary for remainder of the thesis 
The remainder of this thesis will describe the materials and methods used to carry out the 
aims, including the software, strains and laboratory conditions used. Then I will discuss 
the results and discussion concurrently to describe the rationale behind the experiments 
and scientific thought. The thesis will then conclude with an overall summary and 
reference list.  
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2 Materials and Methods 
2.1 Bacteriophage endolysin selection through bioinformatics 
This section will introduce the bioinformatic software that assisted on endolysin 
confirmation through detailed output. 
2.1.1 Online databases and tools; PhagesDB and NCBI BLASTp annotations 
Two sequenced mycobacteriophages from each cluster (including sub clusters where 
appropriate) were selected from PhagesDB with the position of each lysin A, lysin B, 
holin (if present) and the amino acid sequences of these proteins recorded (PhagesDB, 
2017). Each endolysin amino acid sequence was run through NCBI Standard Protein 
BLASTp to see if the annotated function is correct compared to other bacteriophage 
functions by e-value comparison. The database selected was Non-redundant protein 
sequences (nr) using the programme search algorithm blastp (protein-protein BLAST). 
The default parameters under the blastp algorithm included maximum of 100 target 
sequences, automatically adjusting parameters for short input sequences, expected 
threshold of 10, word size of six and zero maximum matches in query range. The scoring 
parameters included the default BLOSUM62 matrix, gap costs were 11 existence, 
extension 1 with conditional compositional score matrix adjustment. 
2.1.2 Clustal Omega 
All amino acid sequences from the selected mycobacteriophages were separated into 
“Lysin A” and “Lysin B” categories. It was decided at this stage to disregard the holin 
protein as this protein has a specific purpose within inter-cell bacteriophage lysis with no 
significant effect proposed for exogenous lysis. The Clustal programme was clustalo, 
version 1.2.4 (Goujon et al., 2010; McWilliam et al., 2013; Sievers et al., 2011). A set of 
proteins were selected for sequence analysis and the remaining default input parameters 
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were selected. The output format was ClustalW with character counts and input sequences 
not dealigned. The mBed-like clustering guide tree and clustering iterations were both 
true, with a default number of combined iterations (0), maximum guide tree iterations and 
HMM iterations. The output order was aligned. 
2.1.2.1 FigTree 
Using the amino acid sequence from each bacteriophage lysin A or lysin B gene identified 
from DNAMaster, FigTree v1.4.3 was used to make a phylogenetic tree of the output to 
gauge a visual understanding of genetic relationships. 
2.1.3 HHpred 
For further domain confirmation, Fast Alignment Search Tool A (FASTA) files were 
submitted to the Max Planck Institute (MPI) Bioinformatics Toolbox HHpred 
(Zimmermann et al., 2018). The NCBI_Conserved_Domain(CD)_v3.16 was selected and 
the default settings for the programme were used. Briefly, the multiple sequence 
alignment (MSA) generation method was (HHblits=>uniclust30_2018_08) with three 
MSA generation steps with an e-value minimum threshold of 1e-3. The minimum 
sequence identity of MSA hits with query (%) was 0 and minimum coverage of MSA hits 
(%) was 20. The local alignment mode was used, the maximum accuracy (MAC) had no 
realignment and the secondary structure scoring was set during alignment. A total of 250 





















N 28 lysin A 22834 24342 KU935730 
D29 
(lysB) 
A2 12 lysin B 6606 7370 AF022214 
Jaws 
(lysB) 
K1 31 lysin B 26448 27320 JN185608 
Inca 
(lysB) 
E 34 lysin B 30537 31394 MH576956 
Giles 
(lysB) 
Q 32 lysin B 28339 29574 EU203571 
Dylan 
(lysB) 
O 67 lysin B 43515 44555 KF024730 
Bongo 
(lysB) 
M1 38 lysin B 31794 32765 JN699628 
The lysin proteins occur in different regions of each mycobacteriophage genome. The gene numbers in 
each genome are listed along with the start and stop of the ORF and the genome accession numbers. Both 
lysin A’s come from different clusters and all lysin B’s come from different clusters. 
 
2.1.4 Plasmid constructs 
This section of the research was carried out in conjunction with the support and assistance 
of Dr. Eric Altermann in AgResearch, Palmerston North. The N-terminal fusion 
sequences were mRNA stabilised and codon optimised by GeneArt, along with the gene 





2.2.1 Antibiotics, supplements, media,  
 
Table 2: Antibiotic concentrations 
Antibiotic Final concentration 
Ampicillin (AMP) 10mg/ml 
Chloramphenicol (CM) 34mg/ml 
Carbenicillin disodium salt (CB) 50mg/ml 
Cycloheximide (CHX) 10mg/ml 
The antibiotic concentrations were made as above. Throughout the thesis I will refer to them through the 
abbreviated name and the concentration will be known as the final concentration above, unless stated 
otherwise. 
 
2.2.2 Bacterial strains 
 
Table 3: Bacterial strains used in this work 
Bacterial strain Supplied from Reference 
E. coli BL21 AgResearch 
(Jeong, Kim, & Lee, 
2015) 
M. smegmatis mc2155 
American Type Culture 
Collection (ATCC) 
(Mohan, Padiadpu, 
Baloni, & Chandra, 2015) 
We used E. coli BL21 as the host for the PHA expression using the strain to transform the pET-14b plasmid. 
M. smegmatis mc2155 was used as the bacterium specie to test cell death. 
 
2.2.3 M. smegmatis growth 
M. smegmatis was grown in Complete 7H9 media from a frozen glycerol stock of WT 
Mycobacterium smegmatis mc2155. M. smegmatis was streaked out from frozen stocks 
(onto 1.5% LB + CB + CHX plates) and incubated at 37C for 72 hours. One colony was 
then picked and added to 50ml of Complete 7H9 and 250l 20% Tween80 for a further 
incubation period at 37C, shaking at 250rpm for 72 hours. For experiments using a 
bacteriophage, Tween80 was not used as it has been shown to inhibit adsorption of 
mycobacteriophages on the bacteria (White & Knight, 1958). This working stock was 
kept at 4C for 5 weeks. Working stocks of M. smegmatis culture were used to make 
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actively growing cultures by taking 50l of the stock added to the 7H9 Complete media 
and incubated at 37C for 72 hours. Cultures were refreshed monthly for backup stocks, 
although M. smegmatis can still be usable for up to six months refrigerated at 4C. 
2.2.4 Growing and maintaining bacteriophage 
Bacteriophage Inca (NCBI:txid2283256) was isolated on M. smegmatis mc2155 from soil 
in New Zealand and purified using the SEA-PHAGES guide (PhagesDB, 2015; SEA-
PHAGES). Inca was frozen in glycerol and kept in the -80C freezer until required. 
2.2.5 Transforming chemically-competent E. coli BL21 
2l of lyophilised plasmids was added to 60l already-chemically competent E. coli 
BL21 cells thawed on ice and heat shocked for 45 seconds on a 42C heat block. These 
cells were put back on ice with 250l of SOC broth, mixed gently and shaken at 200rpm 
at 37C for 45 minutes. To observe colonies, 10l of cells was spread onto 1.5% LB + 
AMP plates and incubated at 37C overnight. 
2.3 Nanobead production 
For each successfully transformed plasmid, a single ampicillin resistant E. coli colony 
was picked and added to 5ml LB + AMP and incubated at 37C shaking at 160rpm, 
allowing cells to grow in excess overnight. The following day, flasks of 100ml LB + AMP 
+ CM and 20% glucose were added along with 2ml of the overnight E. coli culture. These 
flasks were then incubated at 37C, shaking at 200rpm for two hours. 1.5 hours into the 
procedure, 1ml from a flask was extracted and tested at OD600 – all flasks remained 
incubating until the two hours was complete, to reach an OD600 of close to 0.5. When 
OD600 ~0.5 was reached, 1ml of IPTG was added to each flask to induce expression the 
pET-14b plasmid which initiated the production of the PHA beads from the E. coli 
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(Abedi, Beheshti, Najafabadi, Sadeghi, & Akbari, 2012). They were then incubated at 
20C shaking at 160rpm for 48 hours. 24 hours through this procedure, a Nile red stain 
was carried out (described below) on a sample to visualise the nanobead expression within 
the E. coli under microscopy. After 48 hours of expression, the cells were separated into 
two balanced 50mL Falcon Tubes before centrifuging at 5,000g for 10 minutes. The 
supernatant was then discarded and the pellet frozen until the bacterial lysis commenced, 
as illustrated in Fig. 7. 
  
Figure 7: Production of PHA nanobeads with fused endolysins 
A) the chemically competent E. coli BL21 containing pET-14b and PhaC plasmids are streaked out and 
one colony is picked into B) fresh media to incubate overnight. C) a sub-culture of 2ml overnight culture 
was transferred into fresh media and incubated until OD reached ~0.5 before inducing with IPTG and 
incubating for a further 48 hours. D) the E. coli is spun down, pelleted (discarding supernatant) and frozen 
until further use or lysed overnight. E) the pellet is resuspended in lysis buffer, lysozyme and DNase, 
standing at 4C overnight. F) solution is sonicated and G) placed in glycerol gradient for ultra-centrifugation 
to isolate a white band of pure beads before H) spinning to pellet and remove excess glycerol then I) storing 




2.3.1 Nile Red stain 
In order to visualise bead production, 1ml of sample was resuspended in 1ml PB 
(Phosphate Buffer) and 10µl of Nile red stain (0.05g/ml) before pelleting. This was 
repeated twice before finishing off with a final resuspension. 10µl of sample was 
examined under 100X microscopy using an Olympus BX-61 microscope and Nile Red 
stain to identify what cells had produced PHA nanobeads. This step was used to visualise 
the expression of the nanobead and if no nanobeads were visible, the culture would be 
remade. 
2.3.2 Bead extraction 
In order to extract the beads from the cells the bacterial pellet was lysed by resuspension 
in 10mL lysis buffer and 1mL lysozyme. This was left agitating in an icebox at 100rpm 
for 2-3 hours or until the solution became a mucus-like consistency. 150µL of 1000U 
DNaseI was then added to the mucus-like lysed resuspension and this solution was gently 
inverted to mix and then stored in the 4C fridge overnight. The following day the sample 
was put through the sonicator as a physical lysis measure alongside the chemical lysis.  
2.3.3 Ultrasonic Processor 
Sonication at Massey University, Albany, was carried out using the Misonix Sonicator 
Ultrasonic Processor S-4000 for additional physical cell lysis. The microtip was cleaned 
with ethanol wipes before use and the solution of chemically lysed E. coli cells were taken 
up to 40ml with the addition of PBS and vortexed before being placed on ice for 
sonication. Programme settings were programmed as follows; Amplitude: 60, Process 
Time; 10 minutes, Pulse-ON Time; 30 seconds, Pulse-OFF Time; 30 seconds. Halfway 
through the elapsed time (at 5 minutes), the sonication process would be paused, and the 
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sample taken out and shaken to resuspend E. coli cells for maximum sonication 
opportunity. 
2.3.4 Bead purification and storage 
The collected solution was topped up with phosphate buffer (to a total volume of 40ml) 
and centrifuged at 8,000g for 20 minutes at 4C. The supernatant was discarded before 
the pellet was resuspended with 4mL of 50mM phosphate buffer ensuring that it did not 
become too foam-like to distort the gradient. A glycerol gradient with 4mL of 88% 
glycerol on the base, 4mL of 44% glycerol in the middle and 2mL of resuspended pellets 
was made up in polypropylene tubes. The remaining bead solution was split across the 
tubes and balanced within 0.01g. The beads and glycerol gradients were centrifuged using 
an ultracentrifuge TW-641 rotor for 1 hour 45 minutes at 35,000g. At the conclusion of 
the centrifugation, the white band at the glycerol gradient interface was removed with the 
upper layer of glycerol discarded and the intermediate white band poured into a Falcon 
tube topped up to 45mL with PB, gently shaken and centrifuged at 8,000g for 20 minutes 
at 4C to separate the purified nanobeads from the glycerol that may have become mixed 
in during the ultra-centrifugation process. The supernatant was then discarded, and the 
bead pellet was resuspended in phage buffer to a concentration of 20mg/ml with the 
addition of 20l/ml Tween80 to prevent clumping. These were stored indefinitely at -
80C or until required for further experiments. Once in use, the tube of nanobeads was 
kept in the fridge at 4C and not continuously frozen/refrozen.  
2.4 Testing cell death of M. smegmatis 
In order to determine the degree of cell death in populations of M. smegmatis that the 
nanobead exposure could induce in liquid, a series of exposure times and concentrations 
were tested as follows; 45 minutes and 5 hours and concentrations of 10mg/ml, 20mg/ml 
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and 80mg/ml per time allocation. There were these six experimental controls in this 
research, each with three replicates of M. smegmatis culture. For example, 10mg/ml 
nanobead exposure: 50l of nanobeads were added to 1ml M. smegmatis culture (as 
stocks were stored at 200mg nanobeads, per ml of PBS, 20mg/ml for either 45 minutes 
or 5 hours. The control M. smegmatis culture had 5l PBS added as this is what the 
nanobeads were stored in. Controls with similar volumes of PBS were used for each 
concentration.  
Unless otherwise specified, these infections would be carried out at room temperature 
(21C) using a standing culture of M. smegmatis stored at 4C. Each time point and 
concentration of nanobeads would have a corresponding M. smegmatis control that 
remained at room temperature for the duration of the exposure experiment. 
2.4.1 Test one: detecting cell death through fluorescent microscopy 
The above infections were carried out and 4l/ml of 1.67mM SYTO 9 nucleic acid stain, 
18.3mM propidium iodide fluorescent stain solution in DMSO was added, mixed in and 
2l was placed onto an M9 + glucose 1% agarose pad. Once the 2l bead solution had 
set, a coverslip was placed on the pad and examined under the Olympus BX-61 
microscope using an Olympus U-RFL-T fluorescent lamp and microscope settings of 
50ms GFP and 30ms RED. Images were captured using the cellSens Dimension software. 
To calculate cell death, images were merged in Fiji Image J software. Green cells were 
recorded as “alive” and red cells were recorded as “dead”. Unstained beads were also 
photographed under the microscope, measuring 100 unstained beads at a 10-1 dilution on 
Fiji Image J software. 
39 
 
2.4.2 Test two: detecting cell death through a plate-reader assay 
For this experiment, the concentration of nanobead exposure to M. smegmatis were set 
up as aforementioned in section 2.4 with three replicates as well as untreated M. 
smegmatis, water, empty wells and wells with an autoclaved glass bead in them, in a 
Greiner 96 well flat bottom plate. 
Each well of the 96-well plate contained a particular concentration of nanobead 
(discussed above) exposed to a series of M. smegmatis dilutions from 100 – 10-11. 100l 
of each sample was placed into a well as there would be fast shaking and 100l would 
minimise the risk of contamination from overflow. A second set of trials involved the 
same set up but with an autoclaved glass bead to stimulate aerobic growth of M. 
smegmatis. This experiment was not set into the 45 minute and 5 hour time allocations 
for nanobead exposure as the experiment was run over a 24 hour timeframe. 
The plate reader software was Gen5 2.06 and each experiment was run for 24 hours 
continuously shaking fast, the temperature set at 37C, kinetic run, three replicates read 




2.4.3 Test three: detecting difference in colony counts 
The first part of this experiment looked at the difference in colonies due to cell death 
caused by the nanobeads upon exposure. The bead exposures were set up as below in Fig. 
8. After the two time points of 45 minutes and 5 hours, the exposure tests were serially 
diluted in 7H9 Complete media, 100l of 10-6 dilution was added to a 1.5% LB + CB + 
CHX plate and spread using autoclaved glass beads. These plates were then inverted and 
incubated at 37C for 72 hours. After 72 hours, colonies were counted across each of the 
plates, Fig 8. 
  
Figure 8: Testing cell death induced by bead exposure by colony count 
A) a specified concentration of nanobeads are added to a standing culture of M. smegmatis at room 
temperature and B) left standing for a specified period of time. The nanobeads are then C) serially diluted 
and spread across an agar plate and incubated before D) counting the difference in colonies between the 




2.4.3.1 Testing for resistant colonies 
The second part of this experiment aimed to understand if the remaining colonies were 
resistant to endolysins or if there had not been enough endolysin nanobeads to achieve a 
higher percentage of cell death. This was done by picking a colony from each plate with 
the highest cell death, growing it with the same preparation as above, and repeating the 
80mg/ml 5 hour experiment to compare the cell death between the different cultures. 
 
2.4.4 Test four: detecting cell death using filter paper for a proof-of-concept 
applied approach 
Because hospital masks are hydrophobic and require commercial spray coaters, Grade 1 
filter paper was used as a hydrophilic alternative. 1cm diameter filter paper pieces were 
autoclaved before use. Each concentration of nanobead solution was spread across the 
filter paper, let dry for ~5 minutes before spraying one spray of 10-5 M. smegmatis using 
a cosmetic atomiser which dispenses 100l bacteria per spray using the contraption in 
Fig. 9. Each piece of filter paper was then left for 15 minutes before stamping onto a 1.5% 
LB + CB + CHX plate, inverted and incubated at 37C for 72 hours. This crafty solution 
was created using a Harris Uni-Core-2.00 borer to make a small hole in an Eppendorf 
tube to put the tube of the spray nozzle into. This way, we were able to see exactly how 





2.4.5 Statistical analysis 
Additional data analysis of results was carried out using Microsoft Excel 16 and RStudio 
version 1.1.46. 
  
Figure 9: Lab-made spray system 
Using the Harris Uni-Core-2.00 to make a hole in the Eppendorf tube, the experiment can use smaller 
volumes than the bottle that a traditional cosmetic atomiser bottle would hold (~30mls) and also to control 




3 Results and Discussion 
This section will include the motivation and results of each experiment alongside a critical 
analysis of results and a discussion of the interpretation. Both positive and negative results 
are included as they both had an impact on future directions. The results come in three 
parts; the selection of the endolysins for this work, expressing the endolysins on the 
nanobeads and testing the endolysin-nanobead fusions for their effect on cell viability.  
3.1 PART ONE: Gene selection process and domain confirmation 
The purpose of this project was to identify lysin proteins that would be capable of lysing 
M. smegmatis “from without” using the vast resource of completely sequenced 
mycobacteriophages available from PhagesDB. Ultimately, the aim was to attach these 
proteins to biodegradable nanobeads. Herein, I will describe the process that was 
undertaken in order to choose the type of proteins, the specific genes and how the identity 
of the proteins expressed from those genes was verified bioinformatically. 
3.1.1 Rationale behind choosing the final mycobacteriophage endolysin 
candidates 
Mycobacteriophage endolysins were selected for this project. In order to make the best 
use of these experiments we wanted to choose Lysin A and Lysin B genes for synthesis 
and expression in a nanobead expression vector, however we wanted the endolysins to be 
different from one another. Our strategy for choosing different genes is discussed below 
through four bioinformatic steps. This project required simple and practical lytic enzymes 
with the structural and biochemical simplicity to allow them to act as lytic agents when 
applied to M. smegmatis exogenously, fused to biodegradable nanobeads. (K. Payne et 























Figure 10: Cladogram of a selection of lysin A mycobacteriophages (clusters labelled) 
The two mycobacteriophages highlighted in blue illustrate the two final candidates selected for the project; 
StarStuff and Pipsqueaks. We can see from this tree that the cluster A mycobacteriophages are close 
together, indicating similarity in lysin A amino acid sequence. StarStuff was chosen as it is one of the 
cluster A mycobacteriophages and it is closely related to other lysin A’s that have shown “lysis from 
without” in other studies. Pipsqueaks was chosen as it is further away in the phylogenetic tree, amongst a 





Figure 11: Cladogram of a selection of lysin B mycobacteriophages from each cluster (clusters 
labelled) 
The six mycobacteriophages highlighted illustrate the six final candidates selected for the project; Giles 
(Q), Inca (E), Jaws (K1), D29 (A2), Dylan (O) and Bongo (M1). Not only are these six lysin B’s from 
different clusters, they are also distinct on the phylogenetic tree. They are each from a monophyletic clade 




Ultimately, lysin B’s were the focus due to their capacity to “lyse from without”. Lysin 
B of mycobacteriophage D29 was shown to be active against a 5-day standing culture M. 
smegmatis biofilm as an applied protein in concentrations from 1g/ml to 100g/ml to 
(K. M. Payne, 2006). A few lysin A’s were chosen as they lyse the peptidoglycan whereas 
lysin B’s lyse at the junction between the mycolic acids and peptidoglycan component of 
the cell wall (Ford, Sarkis, Belanger, Hendrix, & Hatfull, 1998; K. Payne et al., 2009; 
Pohane et al., 2015). The set of Lysin A and Lysin B genes chosen are represented as a 
cladogram of amino acid similarity in Fig. 10 and Fig. 11. The six mycobacteriophages 
highlighted illustrate the six final candidates selected for the project; Giles (Q), Inca (E), 
Jaws (K1), D29 (A2), Dylan (O) and Bongo (M1). Not only are these six lysin B’s from 
different clusters, they are also distinct on the phylogenetic tree. They are each from a 
monophyletic clade and this diversity was the reason they were selected for this project. 
In order to choose bacteriophage genes that were more likely I chose mycobacteriophages 
from different “clusters”. Clusters are way of grouping similar bacteriophages, in an ad 
hoc fashion that accounts for chimerism that was developed by Graham Hatfull and 
colleagues and applied to the bacteriophages in  PhagesDB. Briefly, bacteriophages that 
display over 50% nucleotide sequence similarity are grouped into the same cluster 
(Hatfull et al., 2008; Sassi et al., 2013). Two bacteriophages were selected from each of 
85 clusters for this project and these bacteriophages represented a geographical spread 
across the world (Fig. 12). I eventually chose a set of two lysin A and six lysin B spanning 
across a total of seven clusters (Table 4, Fig. 10 and Fig. 11). 
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Table 4: NCBI BLASTp output 
Listing the bacteriophage’s closest BLASTp “hit” and the corresponding e-value. * the second best hit was 
described as a “lysin B” with the same scores as CJW1 (except the identity which was 99%) and there was 
significant evidence to show that CJW1 was also a lysin B, unannotated. ** the second best hit was also 
described as a “lysin B” with the same scores as Corndog (except the alignment score which was 713 and 
the identity which was 99%) and there was significant evidence to show that Corndog was also a lysin B, 
unannotated. 
 
I used bioinformatic tools BLAST and Clustal to analyse the active domains of my lysins 
following on the model of Payne and Hatfull (K. M. Payne & Hatfull, 2012). All eight of 
the endolysins chosen (Table 4) were confirmed to be endolysins in BLAST by having e-
values of at least 10-5 or similarity scores of at least 20%. This rough bioinformatic 
analysis enabled the positive identification of hydrolase family domains that were also 

































































662 100 0.0 100 YP_008050970.1 
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3.1.2 Checking for evidence of lysin function using NCBI BLASTp 
The bacteriophages in the PhagesDB database have been discovered, sequenced and 
annotated by undergraduates in the SEA-PHAGES programme (Jordan et al., 2014). As 
such, the annotations have been quality controlled within the program and are most likely 
accurate, nevertheless it is wise to double check that there is evidence for functional 
assignment of an annotation. Each of the lysin A and lysin B genes that we chose were 
individually submitted to the NCBI BLASTp database in order to verify that there is 
strong evidence for the annotation call (Fassler & Cooper, 2011). 
Each of the lysin candidates had over 99% identity to an identical lysin protein in at least 
three other matches with e-values of 0.0 indicating strong evidence that the annotations 
were correct and each of the candidates is either a lysin A or a lysin B (Table 4). Although 
the information illustrated in Table 4 shows only the top hit, for every bacteriophage lysin 
output, there were at least three hits with similar statistics providing further evidence 
towards the accuracy of these annotations and less chance of two false-annotations 
occurring to match. 
3.1.3 Bacteriophage selection candidates 
The eight endolysin candidates comprised of six lysin B’s and two lysin A’s are located 
across the North and South hemisphere, throughout three countries encompassing island 
nations and landlocked countries. There were lysins from three different continents, 
spanning three countries across two hemispheres. For example, both a lysin A (StarStuff) 
and lysin B (Dylan) came from South Africa. Although to date we do not know of any 
studies demonstrating an effect of geography on lysin ability or bacteriophage 
characteristics, nevertheless it was interesting to select a group of bacteriophages from 
around the world to include in this project. 
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As aforementioned, D29 was included as a positive control in this experiment with 
previous research from Payne and colleagues demonstrated the lytic effects of D29 when 
it was applied to M. smegmatis biofilms “from without” resulting in a significant decrease 
in biofilm maturation (K. M. Payne, 2006). 
The lysin B from bacteriophage Inca was also included in this project not only as a New 
Zealand bacteriophage representative but also as our laboratory has a frozen stock of Inca 
after my discovery of this bacteriophage in 2015. We can therefore use this bacteriophage 
to compare the lytic ability of lysin proteins to the bacteriophage. This may be important 
since the mechanisms that mycobacteria use to evade infection from mycobacteriophages, 
including SIE, nucleic acid modifications and CRISPR Cas, are expected to be in effect 








Giles (Q), Lysin B 
Pennsylvania, USA 
Bongo (M1), Lysin B 
Missouri, USA 
D29 (A2), Lysin B 
California, USA 
Pipsqueaks (N), Lysin A 
South Carolina, USA 
Inca (E), Lysin B 
Auckland, NZ 
StarStuff (A2), Lysin A 
Pinetown, South Africa 
Dylan (O), Lysin B 
Durban, South Africa 
Jaws (K1), Lysin B 
Louisiana, USA 
Figure 12: Bacteriophage endolysin geographic location 
The eight endolysin candidates comprised of six lysin B’s and two lysin A’s are located across the North 
and South hemisphere, throughout three countries encompassing island nations and landlocked countries. 
Clusters are labelled in brackets. These bacteriophages are all siphoviridae (tailed bacteriophages), however 
Dylan is distinctly different displaying a longer capsid head approximately one third the size of the whole 
bacteriophage. The other bacteriophages vary in tail length but remain true to the siphoviridae morphotype. 
We can see that there is no correlation between phenotypic characteristics of these bacteriophage 




3.1.4 Verifying lysin-like domains are present using HHpred 
The last check we wanted to perform in order to confirm that the eight genes that we had 
selected for this project were true lysins, was to evaluate the domains in each gene using 
HHpred. HHpred used a multiple sequence alignment to detect protein homology and 
conserved domains. 
D29 Lysin B, the positive control in this work causes “lysis from without” through the 
presence of the α/β hydrolase, with a catalytic triad common to cutinases, containing an 
additional four-helix domain involved in the binding of lipid substrates. (K. Payne et al., 
2009). D29 is a mycolylarabinogalactan esterase that functions by cleaving the specific 
ester linking the mycolic acid-rich outer membrane to the arabinogalactan releasing free 
mycolic acids during lysis, is it therefore a crucial component for lysis (K. Payne et al., 
2009). The presence of the α/β hydrolase domain will be a further indication that the genes 
we have selected will act as a lysin in this trial. We used the lysin B amino acid sequence 
from bacteriophage D29 as a primary reference to explore the presence or absence of 
domains that have similar lysin-like activities. Further comparing to the endolysin 
candidates selected from bacteriophage D29 lysin B, this protein was used as a reference 
to explore the presence of lysin-like domains. HHpred outputs give the name of the 
conserved domains that are part of the protein structure found four different conserved 








Name Probability E-value 
StarStuff 
(lys A) 
00325 chitinase_glyco_hydro_19 99.70 7.1e-20 
Pipsqueaks 
(lys A) 
00325 chitinase_glyco_hydro_19 99.75 2.8e-21 
D29 
(lys B) 
00707 Pancreat_lipase_like 96.76 2.2e-4 
Jaws 
(lys B) 
00707 Pancreat_lipase_like 95.72 6.1e-3 
Inca 
(lys B) 
00741 Lipase 94.74 1.5e-2 
Giles 
(lys B) 
00741 Lipase 95.87 2.5e-3 
Dylan 
(lys B) 
00707 Pancreat_lipase_like 94.17 8.6e-2 
Bongo 
(lys B) 
00519 Lipase_3 97.14 2.6e-5 
There are four different conserved domains listed as the top match (highest probability score and lowest e-
value) for each of the lysins. Conserved domains chitinase_glyco_hydro_19 (a chitinase) was observed for 
both lysin A’s, whereas a variation of lipase domains including Pancreat_lipase_like, Lipase and Lipase_3 
were identified for each of the lysin B’s. Upon further investigation, each of these slightly different 
conserved domains have the same function as a lipase. 
 
One conserved domain chitinase_glyco_hydro19 was identified as the top hit for both 
lysin A proteins and although there were three conserved domains for the lysin B proteins, 
they were all associated with lipase activity. The interpretation of the lysin A and lysin B 
analyses are discussed further below.  
3.1.4.1 Lysin A domain analysis  
HHpred suggested strong evidence of lytic activity for StarStuff and Pipsqueaks with the 
chitainse_glyco_hydro_19 hit observed with over 99.7% probability for both lysin A’s. 
HHpred lists this class of chitinase as “Glycoside hydrolase family 19 chitinase domain. 
Chitinases are enzymes that catalyse the hydrolysis of the beta-1,4-N-acetyl-D-
glucosamine linkages in chitin polymers” (Zimmermann et al., 2018). Payne and 
colleagues identified lysin A candidates that also contain the 00325 chitinase domain and 
Catalão and colleagues noted that this domain has previously been identified mainly in 
cluster A mycobacteriophage (StarStuff is cluster A2), however there is little information 
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listed about chitinase presence in cluster N mycobacteriophages, which is the cluster of 
Pipsqueaks, although there is no evidence to suspect the contrary (Catalão & Pimentel, 
2018; K. M. Payne & Hatfull, 2012). Based on the earlier definition of clusters from 
Hatfull and colleagues, the assignment of mycobacteriophage to clusters does not appear 
to correlate to any significant difference in lysin domain characterisation at this stage due 
to the highly mosaic nature of bacteriophage evolution and both inter-cluster and intra-
cluster relatedness reveals a continuum of genetic diversity (Pope et al., 2015). We 
hypothesise that a reason for clusters to not be informative is the highly mosaic nature of 
bacteriophage evolution which means that each bacteriophage genome can be considered 
as a unique combination of modules that are exchangeable throughout the population 
(Hatfull, 2008). Once again, the inclusion of clusters in the early stages of this research 
was just to help group bacteriophage so we had a pool of largely differing bacteriophages. 
Proteins that encompass chitin-like domains generally act on the β-glycosidic linkages 
that are present in chitin and the peptidoglycan cell wall components (Catalão & Pimentel, 
2018). These data therefore further support the assignment of lysin A properties to the 
two selected lysin A genes that are annotated in StarStuff and Pipsqueaks, both of which 
we will use for nanobead expression. 
3.1.4.2 Lysin B domain analysis 
In comparison, the conserved domains for the lysin B candidates suggest they are part of 
the lipase domain class. Basing the previous extensive research around lysin B lytic 
activity of D29, the D29 domains will form the basis of this analysis. It can be seen in 
Table 5, that D29, Jaws and Dylan share an identical match as the top hit; 
Pancreat_lipase_like, which HHpred describes as “Pancreatic lipase-like enzymes. 
Lipases are esterases that can hydrolyse long-chain acyl-triglycerides into di- and 
monoglycerides, glycerol, and free fatty acids at a water/lipid interface” (Zimmermann et 
54 
 
al., 2018). Similarly, to the lysin A cutinases, lysin B lipases, cutinases and esterases are 
all lipolytic enzymes, members of the serine hydrolase family that all fall into the large 
α/β hydrolase superfamily (Arpigny & Jaeger, 1999; Catalão & Pimentel, 2018; Z. Chen 
et al., 2007; Gupta, Gupta, & Rathi, 2004). The activity of these lipases is centred around 
the catalytic triad of specifically ordered Ser, Asp (or Glu) and His amino acid sequences, 
identified through the crystalline 3D structure of D29, Fig. 3, the Ser amino acid is highly 
conserved (Catalão & Pimentel, 2018). The primary lipase domain demonstrates the 
underlying lytic ability under the α/β hydrolase family, and the subsequent hits still fall 
into the hydrolytic enzyme classes. 
Conserved domain 00741; Lipase, was the top hit for Inca and Giles. HHpred describes 
the lipase domain as “Lipases are esterases that can hydrolyse long-chain acyl-
triglycerides into di- and monoglycerides, glycerol, and free fatty acids at a water/lipid 
interface” (Zimmermann et al., 2018). This definition is only slightly modified from that 
of conserved domain 00707 with the basic lipase function described. Therefore, we can 
be confident that these domains are very similar in function, suggesting further evidence 
towards correct annotation and proposed lytic ability for Inca and Giles too. 
Bongo was the only lysin B with a top hit independent of the other five lysin B’s; lipase_3. 
Nevertheless, the HHpred definition of lipase_3 is identical to domain 00741 “Lipase” 
suggesting the overarching function is based on the same lytic principles. 
We can be confident progressing further into the pET-14b plasmid fusion and 





3.1.5 PhaC pET-14b plasmid construct 
 
  
Figure 13: pET-14b endolysin fusion plasmid constructs 
Designed by Eric Altermann (AgResearch) using Plasmid Map Enhancer for Windows 95. All molecules 




Once the endolysins were chosen and their annotations were verified, each of the eight 
amino acid sequences was subjected to mRNA stabilisation and codon optimisation for 
expression in an Escherichia coli background by Eric Altermann (AgResearch) using the 
on-line tools available from DNA synthesis company, GeneArt. The pET-14b expression 
vector is comprised of a lacI gene that encodes a lac repressor, a lac operator, a T7 
promotor that is specific for RNA polymerase, AMP resistance gene and an origin of 
replication (Fig. 13). The vector is designed to overproduce proteins fused to the surface 
of the nanobead by enabling high expression by the T7 RNA polymerase as a result of E. 
coli BL21 production. 
More specifically in this project, the mycobacteriophage endolysins (lysin A and lysin B) 
were each incorporated into the pET-14b expression vector and then transformed into E. 




3.2 PART TWO: Expression and production of biodegradable lysin 
nanobeads 
This section discusses the results of making the biodegradable nanobeads with lysins 
fused to the surface in vitro both in AgResearch, Palmerston North, as well as Massey 
University, Albany Campus. 
3.2.1 Establishing expression of PhaC in E. coli with a Nile Red stain 
Once the expression vectors were created they were transformed into E. coli and 
expressed. Briefly, transformation of the expression vectors was confirmed by selection 
on Amp LB plates (see materials and methods). Cultured representative single colony 
isolates were frozen down at -80ºC. Cultures of each plasmid were induced (see Materials 
& Methods) and Nile Red stain was used to visually confirm the PHA nanobeads within 
living E. coli cells (Fig. 14). Nile Red dye is a hydrophobic fluorogenic dye that associates 
strongly with the PHA (Peters & Rehm, 2005; Robins, Hooks, Rehm, & Ackerley, 2013). 
Nile Red was used to identify the presence of PHA nanobeads prior to E. coli cell lysis 
and also as a qualitative method to determine the yield percentage of each lysin nanobead 







3.2.2 Purifying nanobeads 
Table 6: Amount of nanobeads harvested 
Lysin 
Amount of nanobeads 
harvested (mg) 
StarStuff (LysA) 589.9 
Pipsqueaks (LysA) 387.2 
D29 (LysB) 366.0 
Jaws (LysB) 453.0 
Inca (LysB) 473.1 
Giles (LysB) 908.0 
Dylan (LysB) 447.2 
Bongo (LysB) 344.9 
PhaC (no lysin) 331.4 
A) Table 6. All of the beads yielded at least 300mg of nanobeads. This data was an average of each of the 
nanobead productions because the tests for cell death often required more production of these nanobeads. 
There does not appear to be any relationship between the type of lysin and the amount of nanobeads 
harvested. 
A B 
Figure 14: Nile Red stain to detect presence of lipid nanobeads 
After the expression of PhaC in the nanobeads through the growth of the E. coli culture induced with IPTG, 
a small volume of beads were treated with Nile Red stain and visualised under the fluorescent microscope 
to estimate yield. This photo is of the lysin B D29 nanobeads and illustrates the beads that have picked up 
the stain due to the presence of lipids and have fluoresced red. This evidence was used as further evidence 
of bead presence prior to lysis. 
 
B) Figure 15: Purified nanobeads indicated by the white band in the glycerol gradient 
These beads were then separated into a Falcon tube by pouring off the glycerol and centrifuged. Beads that 
were contaminated could not be observed in a white band, instead a sticky white precipitate at the bottom 
of the polypropylene tube. 
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3.2.3 Dealing with contamination 
When making the lysin nanobeads for the first time at AgResearch, Palmerston North, 
there appeared to be contamination in the beads when streaking them out on 1.5% LB 
plates. The suspect colonies looked similar to the E. coli colony morphology that had 
been observed with the E. coli BL21 transformed with the plasmid. To confirm this, we 
streaked out the beads on 1.5% LB + AMP + CM which WT bacteria would be sensitive 
to and not grow, however the E. coli BL21 contamination persisted, suggesting this was 
the cause of the contamination (Fig. 16). The cause of contamination was probably 
insufficient lysis. Although the aseptic practices differed greatly at either institution, this 
could not be ruled out as the cause. At the Massey University, Albany, the chemical lysis 
using lysis buffer, lysozyme and DNaseI stayed constant, yet the physical lysis step 
changed from using a microfluidiser at AgResearch to a sonicator at Massey University. 
I had to change the lysis method when travelling between laboratories, yet the change in 
physical lysis technique appeared to result in more lysis and therefore less contamination 






A Gram stain was carried out on representative contaminating colonies. As can be seen 
in Fig. 17 below, the pink, rod shaped cells are indicative of Gram-negative E. coli and 
as a result better physical lysis approaches were ensured when moving on to produce 
more endolysin nanobeads. 
Figure 16: Contamination across increasing dilutions 
A) We can see that the number of colonies correlates to the increase in dilution, with each increase in 
dilution resulting in a 10-fold decrease in colony counts, especially visible for Pipsqueaks and D29. This 
suggests that the contamination is from the bead solution rather than a chance contamination on a few 
plates. B) The medium sized, round, off-white colony morphology initially suggested E. coli as the likely 
contaminant. Because this laboratory does not work with this strain of E. coli beyond this project, it is 
likely that this is a result of insufficient lysis. 
 
Figure 17: Gram stained contamination indicated Gram-negative bacterium present 
The pink stained rod shapes are indicative of a Gram-negative bacterium and the persistence in LB plates 
supplemented with AMP and CM yet the sensitivity to CB and CHX suggest E. coli contamination. Gram- 
negative bacteria have a thin peptidoglycan layer and outer membrane, therefore they do not take up the 
primary stain, instead retaining the secondary counterstain (sarafin) illustrating a pink/red colour. 
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3.2.4 Endolysin nanobead size differences 
In order to establish what physical differences might appear in the nanobeads due to 
fusion and expression we sent samples of the nanobeads for EM. The nanobeads ranged 
in size from averages of 0.434m ± 0.149 through to 1.787m ± 0.456 (Fig. 18). This 
box and whisker plot illustrates the difference in mean lysin length in relation to the lysin 
type. For example, both StarStuff and Pipsqueaks who were lysin A’s have mean lysin 
lengths of 1.787m ± 0.456 and 1.722m ± 0.409. This is different to the lysin B lengths 
which average from 0.592m ± 0.0123 to 0.896m ± 0.0226. A two sample t-test of the 
average nanobead sizes of lysin A’s compared to lysin B’s revealed a p-value of 4.34x10-
6, which indicated an extremely significant difference to the lysin B lengths which average 
from 0.592m ± 0.0123 to 0.896m ± 0.0226. 
 
Table 7: Endolysin nanobead mean bead sizes 
There is a significant difference (p=4.34x10-6) in the size of endolysin nanobeads between lysin A, lysin B 
and the negative control of PhaC. The largest two bead sizes were StarStuff and Pipsqueaks (both lysin A) 
and the smallest was the negative control (PhaC). 
  
Lysin name Lysin type Mean bead size 
PhaC No lysin 0.434 ± 0.0149 
StarStuff lysin A 1.787 ± 0.0456 
Pipsqueaks lysin A 1.722 ± 0.0409 
D29 lysin B 0.640 ± 0.0189 
Jaws lysin B 0.757 ± 0.0232 
Inca lysin B 0.616 ± 0.0171 
Giles lysin B 0.896 ± 0.0226 
Dylan lysin B 0.592 ± 0.0123 





Figure 18: Endolysin nanobead size differences 
PhaC (negative control with no endolysin N-terminal fusion) has the smallest size. The lysin A candidates, 
StarStuff and Pipsqueaks have the largest bead sizes, whilst there is also a noticeable difference between 











Figure 19: Scanning Electron Microscopy of three lysin nanobeads 
A) PhaC nanobeads with no endolysin attached. The mean size of these beads is 0.434m ± 0.0149. B) 
StarStuff nanobeads with lysin A fused to the surface. The mean size of these beads is 1.787m ± 0.0456. 
C) D29 nanobeads with lysin A fused to the surface. The mean size of these beads is 0.640m ± 0.0189. 





Figure 20: Phase contrast 100X microscopy of unstained lysin nanobeads 
Unstained phase-contrast microscopy illustrates the significant size difference between the lysin A and lysin 
B nanobeads. 
PhaC StarStuff (lys A) Pipsqueaks (lys A) 
D29 (lys B) Inca (lys B) Jaws (lys B) 
Dylan (lys B) Giles (lys B) Bongo (lys B) 
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Nanobead fusions to lysins appear to have significantly different sizes, depending on the 
type of lysin (Table 7, Fig. 18 and 20). This was unexpected and may implies some 
complex biochemical process in action with the different Pha phasins regulating PHA 
accumulation thus controlling size as well as composition given the particular fusion 
protein (Możejko-Ciesielska & Kiewisz, 2016; Singh, Kumar, Ray, & Kalia, 2015). This 
could be a potential reason as to why the size of the two lysin A’s are similar to each 
other, and the six lysin B’s are also similar in size, however neither lysin type is similar 
to the other overall. 
Two main hypotheses were suggested as a possible explanation of this result. The first is 
that perhaps the lysin A nanobeads are much bigger because there is oligomerisation 
between the C-terminal binding sites of the lysin interacting with each other, resulting in 
a folding of the protein or larger clumping as the lysin proteins join into an oligomer. 
When looking at Fig. 19, the beads in StarStuff do not appear any less circular than their 
smaller counterparts PhaC in nor D29.  
Plenty of research presents the idea that holins form holin-oligomerisation compounds 
when creating a lesion hole in the cell wall for the endolysin to make contact with 
(Catalão, Gil, Moniz-Pereira, & Pimentel, 2011; Gründling, Bläsi, & Young, 2000; Saier 
& Reddy, 2015). Catalão and colleagues demonstrate evidence of mycobacteriophage 
Ms6 lysin A proteins oligomerising with a holin after expressing lysin A (GP4) and holin 
(GP5) monomers through E. coli BL21 membrane fractions and running a Western blot 
and observing bands indicative of monomers, dimers, whilst also concluding that the final 
degree of oligomerisation of lysin A is not yet known (Catalão et al., 2011). The 
oligomerisation potential of the Ms6 lysin A may indicate the risk of oligomerisation with 
just lysin A monomers such as StarStuff and Pipsqueaks in this trial. 
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An additional hypothesis is that the lysin B proteins that target the peptidoglycan cell wall 
are interacting with the E. coli cell wall during expression and lysis for nanobead harvest. 
Consequently, Gram-negative E. coli does not have any mycolic acids, as seen in cell 
wall Fig. 2, which is a unique component of the mycobacterial cell wall. As a result, there 
could be some biological activity between the peptidoglycan hydrolase lysin B during the 
isolation process. This will be further explored in section 3.3 as the efficiency of the lysin 





3.3 PART THREE: Testing antimicrobial activity against M. smegmatis 
Once the endolysins had been verified and produced in a repeatable, sterile manner, it 
was time to conduct tests of the antimicrobial properties of these nanobeads by exposing 
them to M. smegmatis cultures. A range of tests including live/dead stain microscopy, 
shaking cultures nanobead exposure measured by OD in a plate reader, nanobead 
exposure in static cultures assayed by colony plate counts were attempted first. Late an 
applied test which used either hospital masks or a filter paper analogue and colony counts 
as a proof-of-concept approach. In the last instance, we were interested in seeing the 
degree to which such an approach could be a potential prophylactic tool for health care 
workers treating tuberculosis in developing nations. 
3.3.1 Test one: detecting cell death through fluorescent microscopy 
As an initial start point to visualise the presence of dead M. smegmatis cells as a result of 
the endolysin nanobead lysis activity by exposing M. smegmatis to two different 
concentrations of nanobeads to infect for 5 hours before putting 2l onto an agarose pad 
and using fluorescent microscopy to measure cell death as seen by live/dead staining with 
propidium iodide (see Materials and Methods for detailed methods). 
The results in Table 8 below are relatively consistent; cell death appears to take place in 
a very small number of cells by this measure. Between 2.5% and 11% of cells appears to 
be killed according to this assay. As we considered the results however, we noted the 
presence of completely lysed cells in our microscopy results. We reasoned that if 
nanobead exposure results in complete cell lysis then with completely destroyed cells the 
propidium iodide stain (which has high affinity to DNA) would be unable to stain the 
lysed cells. After a series of tests using microscopy, this experiment was changed due to 
inaccuracy and the second test, using a plate reader was initiated. 
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Live cells (%) Dead cells (%) 
M. smegmatis 
Untreated 97.20 ± 0.025 2.80 ± 0.025 
Untreated 96.90 ± 0.029 3.10 ± 0.029 
PhaC 
(no lysin) 
100 97.23 ± 0.13 2.77 ± 0.13 
800 97.46 ± 0.14 2.54 ± 0.14 
StarStuff 
(lysA) 
100 92.60 ± 0.036 7.40 ± 0.036 
800 92.33 ± 0.46 7.67 ± 0.46 
Pipsqueaks 
(lysA) 
100 91.11 ± 0.41 8.89 ± 0.41 
800 90.99 ± 0.32 9.01 ± 0.32 
D29 
(lysB) 
100 95.87 ± 0.015 4.13 ± 0.015 
800 94.32 ± 0.51 5.68 ± 0.51 
Jaws 
(lysB) 
100 93.40 ± 0.14 6.60 ± 0.14 
800 94.65 ± 0.42 5.35 ± 0.42 
Inca 
(lysB) 
100 92.70 ± 0.25 7.30 ± 0.25 
800 91.58 ± 0.065 8.42 ± 0.065 
Giles 
(lysB) 
100 88.50 ± 0.32 11.50 ± 0.32 
800 92.78 ± 0.78 7.22 ± 0.78 
Dylan 
(lysB) 
100 96.22 ± 0.002 3.78 ± 0.002 
800 95.76 ± 0.18 4.24 ± 0.18 
Bongo 
(lysB) 
100 90.98 ± 0.085 9.02 ± 0.085 
800 94.36 ± 0.096 5.64 ± 0.096 
Table showing the cell death (%) of each M. smegmatis culture after exposure to the corresponding 




Untreated M. smegmatis 
Figure 21: Fluorescent microscopy of M. smegmatis exposed to nanobeads (1) 
Even though the 80mg/ml exposure concentrations have four times higher lysin concentration, there is still 
no significant presence of dead cells that would show up in red. A second difficulty is the fluorescent nature 
of the nanobeads making it difficult to accurately count cells under fluorescence. The scale bar is set to 
5m and each image is one of the three replicates. 
PhaC (10mg/ml) PhaC (80mg/ml) 
StarStuff (10mg/ml) StarStuff (80mg/ml) 




Figure 22: Fluorescent microscopy of M. smegmatis exposed to nanobeads (2) 
Even though the 80mg/ml exposure concentrations have four times higher lysin concentration, there is still 
no significant presence of dead cells that would show up in red. A second difficulty is the fluorescent nature 
of the nanobeads making it difficult to accurately count cells under fluorescence. The scale bar is set to 
5m and each image is one of the three replicates. 
D29 (10mg/ml) D29 (80mg/ml) 
Jaws (10mg/ml) Jaws (80mg/ml) 







Figure 23: Fluorescent microscopy of M. smegmatis exposed to nanobeads (3) 
Even though the 80mg/ml exposure concentrations have four times higher lysin concentration, there is still 
no significant presence of dead cells that would show up in red. A second difficulty is the fluorescent nature 
of the nanobeads making it difficult to accurately count cells under fluorescence. The scale bar is set to 
5m and each image is one of the three replicates. 
Giles (10mg/ml) Giles (80mg/ml) 
Dylan (10mg/ml) Dylan (80mg/ml) 
Bongo (80mg/ml) Bongo (10mg/ml) 
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The fluorescent microscopy test involved exposing M. smegmatis to two different 
concentrations of nanobeads and the percentage of live and dead cells were recorded. 
As can be seen in Table 8 and Fig. 21, 22 and 23, there does not appear to be a lot of cell 
death, even after exposure at the highest concentration of nanobeads (80mg/ml). We 
would expect to see a lot more red cells throughout the microscopy, however this is 
absent. Test three was conducted shortly after to see if these results were indicative of the 
lytic activity of the nanobeads, or if in fact there was no lysis occurring. Another 
limitation to this study was that the nanobeads were extremely fluorescent, especially in 
high quantities and we were only able to view a small section under microscopy. 
There also appear to be a few anomalies in the trend of data. We would expect that any 
cell death beyond what would naturally be occurring in M. smegmatis (2.95% ± 0.15) 
would be attributed to the increase in endolysin concentration from 10mg/ml to 80mg/ml. 
We can see that in Bongo, there is more cell death in the lower concentration of 10mg/ml 
and that is the same situation for Pipsqueaks, Jaws and Giles. 
To conclude, using microscopy did not appear to be a reliable way to visualise cell lysis 
as any completely lysed cells would not pick up the PI stain or appear red. The next test 
was to use a plate reader to observe the change in optical density (OD) of the cells, where 
lysed cells decrease in optical density that can be tracked through a plate reader (Newton, 
Schofield, Vlahopoulou, & Zhou, 2016).  
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3.3.2 Test two: detecting cell death through a plate-reader assay 
Instead of using a live/dead stain to understand the effect the nanobeads had on the cell 
death of M. smegmatis cultures, a kinetic (shaking) 96 well plate reader experiment was 
set up instead. Because M. smegmatis requires a lot of aeration when growing 
(traditionally grown in an aerated shaking conical flask), we included an autoclaved glass 
ball as one of the control additions to a second set of M. smegmatis wells and 




M. smegmatis 10-1 untreated 
M. smegmatis 10-1 untreated 
with an autoclaved glass bead 
Glass bead only control 
Figure 24: Plate reader graphs of M. smegmatis cell states 
A) M. smegmatis 10-1 dilution demonstrating a standard exponential curve. After testing out a series of 
dilutions, this dilution was the most appropriate to test. B) M. smegmatis 10-1 dilution with an autoclaved 
glass bead to stimulate cell growth through increased aeration. Although only 100l of M. smegmatis 
dilution was added to each well, we hypothesise that the increased aeration through a shaking stimulant (the 
bead) has caused small droplets to stay on the lid and distorted the absorbance reading slightly as C) the 



































































Figure 25: Endolysin nanobead controls in 96-well plate, no bacteria 
There does not appear to be a constant absorbance reading between the nanobeads. Taking size into account, 
we would expect that there would be a larger constant absorbance reading for lysin A’s StarStuff and 
Pipsqueaks as there is more bead mass, however this is only true for StarStuff. Giles and Bongo are both 














































































































































Figure 26: M. smegmatis after exposure to 10mg/ml endolysin nanobeads in the 96-well 
plate reader, shaking 











































































































































We first established the growth curves of the M. smegmatis culture in the 96 well plates. 
We found there was exponential growth under these conditions (Fig. 24). Because M. 
smegmatis requires aerated growth conditions, it seemed reasonable to include the 
addition of a sterilised glass bead to assist with aeration (Tillich et al., 2014). However, 
(Fig. 24) show the addition of the bead increased noise, but not to an appreciable degree.  
We also wanted to test the nanobeads in order to understand if some of them had different 
levels of growth, or absorbance that they caused in the 96 well plates. We therefore put 
the nanobeads alone in the 96 well plate reader and saw that there were different levels 
of OD that remained constant throughout most of the experiment (Fig. 25). This suggested 
to us that perhaps the nanobeads were clumping, resulting in different absorbance 
readings between the nanobeads. This is unlikely related to size as we saw in Fig. 18 that 
StarStuff and Pipsqueaks (lysin A’s) would have had a higher absorbance with a larger 
mass. We also see that Giles and Bongo (lysin B’s) have an average absorbance above 
1.5 too. 
After establishing the growth of the bacterial cells and the optical properties of the 
nanobeads we were prepared to combine these in order to determine if the presence of the 
nanobeads changed the growth dynamics of the cells in 96 well plate readers. We saw 
uneven growth distributions that were difficult to conclude (Fig. 26), however we can 
hypothesise that once again there may be some clumping amongst the nanobeads. 
Nevertheless, we did not observe any prominent cell growth. 
In retrospect it is clear that the plate reader was not the most reliable test of the lytic 
properties of the endolysin nanobeads when exposed to a 10-1 M. smegmatis culture. This 
may be because these cultures were shaking on the fastest setting, in excess of 200rpm, 
making it more difficult for the nanobeads to make contact for long enough to lyse. This 
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is necessary for culturing the M. smegmatis but not ideal for nanobead use. Although lysis 
in natural systems can take only seconds once the holin protein has created access to the 
peptidoglycan component of the cell wall for the endolysin to lyse, in our experiment, the 
endolysins were not in very close proximity to the bacteria, especially in the lower 
dilutions (10mg/ml and 20mg/ml) which may have made it more difficult to make contact 
for long enough time to be able to lyse the cell. Pohane and colleague Jain demonstrated 
cell lysis after 60-90 minutes of continuous infection and Briers and colleagues have 
observed lysis after 15 minutes (Briers, Peeters, Volckaert, & Lavigne, 2011; A. A. 
Pohane & Jain, 2015). Of course, those experiments were carried out inducing an internal 
endolysin-holin co-expression, so those results may not be immediately relevant to a 
nanobead mediated lysis. There is very little literature on the timing of lysis from without, 
yet we hypothesise that the concentration and contact time of endolysins has an impact 
on nanobead mediated cell death.  
Because of this, we moved on to the third experiment, using a standing culture of M. 
smegmatis to expose the endolysin nanobeads reasoning that this was likely to be a more 
reliable test, and a truer mimicry of real-world applications. Spraying nanobeads on 
hospital masks and allowing surface mediated contact is not very similar to a constantly 
shaking emulsion.  
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3.3.3 Test three: detecting difference in colony counts 
3.3.3.1 Testing cell death by exposing M. smegmatis to endolysin nanobeads for 45 
minutes in a standing culture. 
In order to test the effect of nanobead exposure in a standing liquid culture we used 
concentrations of 10mg/ml, 20mg/ml and 80mg/ml in 45 minutes and decided to switch 
our measurements from a live/dead stain approach, which did not account for cells that 
had completely lysed, to a method in which we plated the cells out and counted colonies 
in order to determine the consequences of the nanobeads on the number of live cells. All 
counts were calculated as percentages of cells grown and cultured in the same way 
without nanobeads. We observed variation between each of the replicates, but as the 
concentrations increased we observed a general increase in cell death in comparison to 
the untreated M. smegmatis control and PHA nanobead, which is the PhaC control with 
no endolysin attached (Fig. 27 and Table 9).   
There are distinct differences in the effect of cell death based on concentration of 
endolysin exposed to M. smegmatis. We can see from Table 9, that 80mg/ml is the most 
effective concentration that results in cell death in most of the trials with Giles having the 
most lytic effect causing 71.99% ± 3.30 cell death. Jaws (lysB) and Dylan (lysB) are the 
least effective in cell lysis at 20mg/ml. With only three replicates, we would expect to see 
a different trend towards increasing lysis with more trials completed. When looking at the 
raw data (not displayed), although M. smegmatis cell death remained constant ~3%, each 
of the replicates varied, and as cell death point was calculated in respect to the average 
across the three replicates of M. smegmatis cell death, we can see the variation within 
those plates through the range of points on the graph. 
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A lot of this variation for all endolysin nanobeads occurs around 10mg/ml. It is important 
to realise that this may be due to the low concentrations. Some of the nanobeads clumped 
and as a result, there may be an extremely lytic “burst” of cells if these lytic clumps 
interacted with the bacterial cells, which may be the reason behind the sudden increase in 
cell lysis for lysin B nanobeads Jaws and Dylan, causing 55.56% ± 7.05 and 70.14% ± 
8.87 cell death, respectively. For the unclumped nanobeads, there is less chance of making 
contact with the bacterial cells and if they did, there is less chance that the contact time 
would be long enough to successfully cleave the cell wall components which may indicate 
why the remaining endolysins only cause around ~40% cell lysis. 
Although we cannot claim that there is a significant difference in cell death between D29, 
Giles and PhaC at 10mg/ml, the average cell death of each respective endolysin nanobead 
is still above 30%. As this is the shortest exposure time and lowest concentration, these 
are promising results. 
As the endolysin nanobead concentration increased from 10mg/ml to 20mg/ml, we saw 
an average increase in cell death for each nanobead, except Jaws and Dylan that were 
previously discussed. This observation fits with the well-known idea that an increase in 
concentration correlates with an increase in reaction rate (cell death in this case). At 
20mg/ml, both lysin A nanobeads had a significant effect on cell death, however only 
Inca from the lysin B nanobeads had a significant cell death.  
Nevertheless, at 80mg/ml of nanobeads in the standing culture with M. smegmatis, every 
endolysin nanobead caused a significant cell death. This result indicates that for applied 




   
Figure 27: M. smegmatis cell death after 45 minutes exposure to 10mg/ml, 20mg/ml and 80mg/ml 
nanobead concentrations in a standing culture of at room temperature 





Table 9: M. smegmatis average cell death and significance after 45 minutes of exposure to 10mg/ml, 
20mg/ml and 80mg/ml nanobead concentrations 
Lysin 
Average cell death 
at 10mg/ml (%) 
p-
value 
Average cell death 
at 20mg/ml (%) 
p-value 
Average cell death 




-4.86 ± 8.57 0.228 1.91 ± 3.13 0.380 2.12 ± 12.60 0.469 
StarStuff 
(lys A) 
47.57 ± 15.59 
0.030 
* 





40.10 ± 8.76 
0.011 
* 










55.56 ± 7.05 
0.0028 
** 





41.67 ± 8.01 
0.0083 
** 










70.14 ± 8.87 
0.005 
** 





19.10 ± 4.89 
0.047 
* 
44.79 ± 14.88 0.0531 70.64 ± 1.37 
0.0160 
* 
Two-sample t-test (assuming unequal variance) was performed on the above data in relation to the cell 
death as a result of exposure to PhaC nanobeads (no lysin attached). The most significant difference in cell 
death occurs at a concentration of 80mg/ml. * = p<0.05, ** = p<0.01, *** = p<0.001. 
 
From the results in Fig. 27 and Table 9 above, when the nanobeads are grouped into their 
respective “lysin A” or “lysin B” categories, there is no significant difference between 
the lysin types at 10mg/ml (p=0.212), 20mg/ml (p=0.194) or 80mg/ml (p=0.429). This 
suggests that when applied “from without” there is no difference between the lytic effect 
causing cell death of M. smegmatis at any concentration point. 
However, we can clearly see the decrease in colony number with Giles (lys B) which 
caused the most cell death at 80mg/ml at 45 minutes (71.99% ± 3.30), see in Fig. 28. 
There is significant variation observed in Fig. 27 however, time constraints limited the 
opportunity for more replication. Future directions (discussed later) indicate more trials 








Giles (lys B) 
20mg/ml exposure 
Giles (lys B) 
80mg/ml exposure 
Figure 28: Giles is the most effective endolysin nanobead at 45 minutes 
As the concentration of nanobeads exposed to Giles increases, cell death increases, indicated by the 
decrease in observable colonies from the untreated sample to the 80mg/ml exposure sample. Each of these 
plates is one of three replicates. 
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3.3.3.2 Testing cell death by exposing M. smegmatis to endolysin nanobeads for 5 hours 
in a standing culture 
To understand if the time M. smegmatis is exposed to the endolysin nanobeads has any 
effect on the cell death observed, a second trial repeating the same experiment above, was 
carried out using an exposure time of 5 hours in the standing culture with three replicates 
(Table 10). 
At 10mg/ml, only D29 (lysB) exposure resulted in a significant M. smegmatis cell death 
of 75.81% ± 5.97. This was the highest cell death that D29 caused throughout the three 
nanobead concentrations at both time points. This is an outlier compared to the rest of the 
data, and we would expect that with more trials we would see less cell death at 10mg/ml 
and more at the higher concentrations, not only for D29 but for the other nanobeads too. 
The most cell death was observed when M. smegmatis was exposed to 80mg/ml endolysin 
nanobeads for 5 hours. The most successful nanobead in causing cell lysis was Inca at 
78.87% ± 5.21. It is expected that with further trials using higher concentrations, that we 
would see the percentage of cell death increase. Because endolysins target the cell wall 
components (peptidoglycan and mycolic acids), a high concentration of these lipases 
would result in a higher chance of cell death. In regard to bacterial resistance developing, 
discussed in the introduction, eventually slow bacteriophages have the opportunity to lyse 
after the previous bacteriophage have “sacrificed” themselves. This links back to the 
increase in time being beneficial for lysis opportunity as well as increased concentration 




Figure 29: M. smegmatis cell death after 5 hours exposure to 10mg/ml, 20mg/ml and 80mg/ml 
nanobead concentrations in standing culture at room temperature 





Table 10: M. smegmatis average cell death and significance after 5 hours of exposure to 10mg/ml, 
20mg/ml and 80mg/ml nanobead concentrations 
Two-sample t-test (assuming unequal variance) was performed on the above data in relation to the cell 
death as a result of exposure to PhaC nanobeads (no lysin attached). The most significant difference in cell 
death occurs at a concentration of 80mg/ml. * = p<0.05, ** = p<0.01, *** = p<0.001. 
 
Similarly, to the results from the 45 minute exposure test, the cell death is significant with 
every endolysin nanobead at 80mg/ml. It would once again be important to use this 
concentration if developing a prophylactic treatment. 
From the results in Fig. 29 and Table 10 above, when the nanobeads are grouped into 
their respective “lysin A” or “lysin B” categories, there is no significant difference 
between the lysin types at 10mg/ml (p=0.213), 20mg/ml (p=0.198) or 80mg/ml 
(p=0.137). This suggests that when applied “from without” there is no difference between 
the lytic effect causing cell death of M. smegmatis at any concentration point. 
We can also visually observe the decrease in colonies from Inca (lys B), which caused 
the most cell death (78.87% ± 5.21) at 80mg/ml at 5 hours, seen in Fig. 30.  
Lysin 
Average cell death 
at 10mg/ml (%) 
p-
value 
Average cell death 
at 20mg/ml (%) 
p-value 
Average cell death 




4.42 ± 21.91 0.477 -0.66 ± 22.73 0.337 2.33 ± 9.11 0.132 
StarStuff 
(lys A) 










75.81 ± 5.97 
0.0440 
* 


































Inca (lys B) 
80mg/ml exposure 
Inca (lys B) 
10mg/ml exposure 




Figure 30: Inca is the most effective endolysin nanobead at 5 hours 
As the concentration of nanobeads exposed to Giles increases, cell death increases, indicated by the 
decrease in observable colonies from the untreated sample to the 80mg/ml exposure sample. Each of these 
plates is one of three replicates. 
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3.3.3.3 Conclusion of using colony counts to detect cell death 
In summary, Fig. 31 below illustrates all of the average cell death data across every time 
point and endolysin nanobead concentration trialled. As demonstrated in Fig. 27 and 29, 
both increasing exposure time to the nanobeads and increasing nanobead concentration 
from 10mg/ml to 80mg/ml at each time point can have a significant increase in observable 
M. smegmatis cell death; 45 minutes (p=0.00119) and 5 hours (p=0.00484). 
When comparing the overall lytic effect of 45minutes exposure with 5 hours exposure in 
regards to M. smegmatis cell death, there is no significant effect at the concentration level; 
10mg/ml (p=0.481) and 80mg/ml (p=0.0821). However, there is a significant effect in the 
difference in time on cell death at 20mg/ml (p=0.00265) where exposure to lysin 
nanobeads for 5 hours results in significantly more cell death than just 45 minutes. 
Nevertheless, at the individual lysin level, we can see that the most significant 
concentration for cell death above 70% (average cell death is 71.46% ± 2.39) is 80mg/ml 
nanobeads exposed to M. smegmatis for at least 5 hours. 
This increasing trend is promising for applied trials, where nanobeads would be sprayed 
onto hospital masks to act as an initial barrier of defense against airborne bacterial 
pathogens (such as tuberculosis) when coughed or otherwise transmitted near an orifice. 
In applied settings, these masks would be worn for long periods of time (~5 hours), 
therefore it is important that longer exposure continues to increase cell death rather than 













































































































































































































































































3.3.3.4 Investigating if remaining colonies are resistant 
I observed from my colony forming unit plates that the colonies that appeared to have 
survived exposure to the nanobeads were smaller than M. smegmatis colonies generally 
appear on this media. I was therefore motivated to test these colonies to see if they 
represented a population of mutants that were able to survive against the nanobeads and 
would therefore represent a problem for practical applications or if these represented a 
population that had simply survived by not encountering the nanobeads or lysing. I 
therefore repeated the exposure test in standing liquid cultures with M. smegmatis cultures 
that were derived from survivor colonies. 
The persisting M. smegmatis colonies on the agar plate after exposure to 80mg/ml 
endolysin nanobeads appeared smaller than the colonies otherwise seen. This suggested 
that there may have been a mutation providing the bacteria with additional defense against 
the lytic enzymes, allowing them to survive the largest concentration of endolysin 
nanobeads in the trial, for the longest exposure time of 5 hours (Barsom & Hatfull, 1996). 
To test this, I picked a surviving colony from each of the plates after 72 hours of 
incubation (Table 11), regrew them using the methods discussed earlier and repeated the 
same experiment; exposing M. smegmatis to 80mg/ml of each endolysin nanobead for 5 
hours, before plating and incubating for 72 hours at 37C. The colonies were then 




Table 11: Comparison of M. smegmatis colony morphologies between WT and endolysin nanobead-
surviving colonies 
Lysin nanobead Colony morphology and size 
M. smegmatis survivor colony size 
after 80mg/ml 5 hour exposure (cm) 
M. smegmatis WT 
 






































0.070 ± 0.039 
Scale bar is 0.1cm. There are obvious differences between the colony sizes that survived the endolysin 
nanobead exposure and the WT M. smegmatis and PhaC (no lysin nanobead). The survivors are 
considerable smaller whereas the colonies not exposed to lysins are larger. 
 
  
Figure 32: Comparison of cell death with M. smegmatis WT and M. smegmatis colonies cultured 
from surviving colonies 
In all endolysin nanobeads (except Jaws), we see more cell death when the nanobeads are applied to the 




The cell death observed in Fig. 32, shows similar M. smegmatis cell death between 
initially exposed WT M. smegmatis and the colonies of M. smegmatis that survived 
exposure to each respective nanobead after 5 hours and 80mg/ml. However, given the 
similarities, we can also see that there is in fact a slight increase in cell death when the 
remaining colonies are exposed once again to the endolysin nanobeads. We hypothesise 
that we see increased death due to the sensitivity of these colonies. This hypothesis stems 
from the idea that the remaining colonies may not be resistant, we may just have not 
exposed them to enough endolysin nanobeads to completely lyse the whole population 
and the remaining colonies are those who have just survived and may be sensitive to a 
second round of lysis proteins. A future trial to test this theory would be to keep increasing 
the concentration and to keep culturing the surviving colonies after each round of 
exposure to see if a similar pattern ensues. 
I also wanted to test if these colonies had changed in their sensitivity to a bacteriophage 
sample, as we had mycobacteriophage Inca in the freezer stocks, as well as the endolysin 
nanobead of Inca lysin B. In order to test this I produced a bacterial lawn from each 
surviving colony discussed above and spot testing 3l Inca bacteriophage serial dilution 
100 – 10-9 onto it. This way we were able to understand if cell lysis was able to occur from 
the inside out (as opposed to our proposed mechanism of lysis from without). As can be 
seen in Fig. 33, the most apparent effect is on the StarStuff (lysin A) plate. We see ~3 
plaque forming units (pfu) on every other plate at the 10-6 dilution spot, however we see 
no Inca plaques on the 10-6 dilution spot. On the bacterial lawn from the StarStuff colony 
we can see ~20 pfu/ml on the 10-5 dilution spot, whereas the spots are webbed (too many 
plaques to distinguish the number of plaques) on all of the other plates. This experiment 
was carried out under identical conditions and each 3l Inca bacteriophage spot came 
from the same tube as what was used for the other tests, therefore this would not be a 
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reason to observe the difference. Therefore, we hypothesise that after exposure to 
StarStuff, lysin A nanobeads at 80mg/ml for 5 hours, M. smegmatis undergoes some type 
of mutation that not only enables it to survive, but to better persist against the 
bacteriophage infection compared to the other nanobeads. It is worth noting that the 
bacterial colony that survived the StarStuff nanobead exposure did not have improved 
resistance to the StarStuff nanobead exposure in the second round (Fig. 32). This may 
indicate that the mutation (if there is one) is particular to phage infection or that these 
results are not significant and should be repeated. If the results proved robust, future 
research would involve sequencing each of the persisting M. smegmatis culture to further 







Figure 33: Surviving M. smegmatis colonies cultured and infected by Inca bacteriophage serial 
dilution 3µl spot test 
A) M. smegmatis WT. Remaining bacterial culture made from surviving colonies of B) M. smegmatis WT 
(from incubator). C) PhaC. D) StarStuff (lys A). E) Pipsqueaks (lys A). F) D29 (lys B). G) Jaws (lys B). 
H) Inca (lys B). I) Giles (lys B). J) Dylan (lys B). K) Bongo (lys B). StarStuff shows a 10-fold difference 
in bacteriophage lysis. 
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Hatfull and Barsom refer to examples of phage-resistance in bacteria, including modified 
peptidoglycan components of the cell wall and phage-resistant mutants and often these 
bacteria are resistant to a series of unrelated bacteriophages (Barsom & Hatfull, 1996). 
More specifically, this paper demonstrated that the overexpression of the Mpr gene blocks 
the access of mycobacteriophage D29 to the membrane, inhibits macromolecular 
movements or affects membrane potentials that may be required for translocation of 
bacteriophage DNA across the membrane (Barsom & Hatfull, 1996). In the case of our 
potentially-resistant colonies, it would be more likely that a random beneficial mutation 
has arisen, as any pre-evolved mutation in relation to the specific lysin A protein would 
have been observed to an extent in the other lysin A candidate in this study; Pipsqueaks, 




3.3.4 Test four: detecting cell death using hospital masks as a proof of 
concept applied approach 
It is important that this antimicrobial tool not only causes cell death in laboratory 
environments, but also in situations that mimic real-world practices, such as the 
transmission and infection of hospital workers working with tuberculosis. To test these 
nanobeads as an applied approach, we used a filter paper, similar to hospital masks, 
discussed below. 
3.3.4.1 Coating hospital masks with nanobeads as a proof of concept 
The previous experiment exposed standing cultures of M. smegmatis to the different 
endolysin nanobeads, yet we wanted to attempt a test that would be more similar to a 
surface contact prophylactic. Initially we proposed submerging a generic-brand hospital 
mask in endolysin nanobeads and testing M. smegmatis survival upon contact. However, 
we discovered that these surfaces are hydrophobic and commercial nanobead applications 
use a more intensive adhesive process. The nanobeads were therefore coated onto the 1cm 
filter paper pieces, left to dry before spraying a bacterial spray of 10-5 dilution of M. 
smegmatis spray (~100 l) on each piece of filter paper and then stamping onto a 1.5% 
LB + CB + CHX agar plate before incubating at 37 C overnight for colony forming unit 
counts. 
  
Figure 34: 10µl of nanobeads on filter paper compared to a hospital mask 
The filter paper (left) is hydrophilic which enabled the even coating of nanobeads on its surface, unlike the 





Figure 35: M. smegmatis colonies stamped after exposure to nanobeads on filter paper 
Example of a stamped plate replicate. The overall trend is that as the concentration of nanobeads increased, 
cell death decreased. Using a cosmetic atomiser made it difficult to ensure constant spray across each of 
the filter paper pieces and the small colony counts made it difficult to extrapolate accurate conclusions. 
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The M. smegmatis colony counts varied throughout this experiment, making it difficult to get reliable 





















4.76 ± 4.55 0.368 -11.94 ± 13.20 0.188 10.69 ± 1.80 0.340 
StarStuff 
(lys A) 
17.65 ± 7.98 0.128 26.19 ± 14.48 0.0618 46.22 ± 6.24 0.00286 ** 
Pipsqueaks 
(lys A) 
20.26 ± 8.75 0.107 39.78 ± 7.95 0.022 * 44.89 ± 5.28 0.00223 ** 
D29 
(lys B) 
11.31 ± 6.21 0.221 48.04 ± 17.87 0.027 * 72.38 ± 13.83 0.0216 * 
Jaws 
(lys B) 





18.27 ± 26.90 0.335 29.74 ± 9.28 0.0306 * 45.07 ± 4.63 0.00170 ** 
Giles 
(lys B) 
21.44 ± 17.44 0.226 21.22 ± 40.28 0.258 58.67 ± 21.10 0.0645 
Dylan 
(lys B) 
9.79 ± 9.02 0.326 13.49 ± 12.44 0.117 27.84 ± 6.45 0.0210 * 
Bongo 
(lys B) 
17.30 ± 13.64 0.237 33.56 ± 26.33 0.110 28.70 ± 10.03 0.0581 
The only significant cell death occurred when 80mg/ml of nanobeads were added to the filter paper, with 






Figure 36: Distribution of colony counts 
Example of a stamped plate replicate. The overall trend is that as the concentration of nanobeads increased, 
cell death decreased. Using a cosmetic atomiser made it difficult to ensure constant spray across each of 
the filter paper pieces and the small colony counts made it difficult to extrapolate accurate conclusions. 
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Although the trend of increasing cell death as concentration of endolysin nanobeads 
increases, in comparison to each concentration equivalent in the standing culture, the 
average cell death at each concentration decreased to an average across all endolysin 
nanobeads of 16.95% cell death at 10mg/ml, 29.35% cell death at 20mg/ml and 49.91% 
cell death at 80mg/ml. One possibility for this may have been the irregularity of using 
filter paper with some M. smegmatis cells absorbing in and not stamping out. During the 
third experiment (colony counts to observe cell death), we used a 10-6 dilution of M. 
smegmatis to get countable colonies with 100l plated, however even though the 100l 
aliquot was condensed into a smaller surface area, the pilot test (not shown) indicated we 
would need to decrease the dilution to get countable colonies at 10-5. This experiment was 
repeated several times in order to see colonies and the results were often inconsistent. We 
can also see that in Table 12, the colony counts observed on the M. smegmatis control 
were very inconsistent, often with a range between 50% respective to the M. smegmatis 
control. Because we did not get a sample size of at least 30-300 colonies, it becomes 
difficult to make any definite conclusions about these results without repeating these tests 
further. Fig. 36 illustrates this variation, especially with Jaws and Bongo at 20mg/ml. 
Because this part of the experiment became difficult to complete within the timeframe of 
submitting this thesis, I have decided to present these results to draw some ideas regarding 
the trend of this data. One overall conclusion (granted the small sample size of colonies), 
is that while cell death increases as concentration increases, it does not increase as much 
as the standing culture experiment (test three). One reason these results may have differed 
from the standing culture colony count experiment could be due to the variability when 
using the cosmetic atomiser. Unlike a pipette that dispenses the exact aliquot, there may 
have been variation less or more than the average 100l that each spray released. 
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Nevertheless, Jaws had the highest cell lysis at 75.54% ± 3.15 at 80mg/ml, with D29 
causing the second highest cell death at 72.38% ± 13.83. Inca still had a reasonable cell 
lysis, causing over 45% cell death and coupled with the bacteriophage of Inca that we 
have in the freezer stocks, this would make a potential combinatorial “cocktail” 
therapeutic approach combining the replication ability of the whole bacteriophage and 
the lysin concentration of the nanobead. More trials would provide directions that are 
more accurate.  
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3.4 Summary  
I tested a set of nanobeads that were custom-synthesised and attached to 
mycobacteriophage endolysins in the hopes of developing a tool for easily applying these 
as an antibacterial to surfaces. The hope is that such a tool can improve defense against 
pathogenic bacteria in varying aspects of life from health care, agriculture and food 
production. Through the four main tests carried out, we have discovered that cell death is 
best observed through cultured plates counting the difference in colonies between treated 
and non-treated M. smegmatis colonies. We also concluded that there is no difference 
between the lysis ability of lysin A and lysin B across proteins across trials as they average 
54.84% ± 2.91 cell death by lysin A’s compared to 53.46% ± 3.36 cell death by lysin B’s 
across trials (p=0.428). 
However, we did observe that the effect of time and concentration appeared to have more 
of an impact that the species of lysin used. We observed that 50.17% ± 8.60 death 
happened on average at 45 minutes, 57.45% ± 8.52 death at 5 hours and that increasing 
the concentration from 10mg/ml to 80mg/ml improved cell death by 24.83% at 45 
minutes and 29.42% at 5 hours. 
The final test for this project involved applying the nanobeads to a filter paper surface, 
spraying with bacteria and stamping these onto agar plates. As a result, we saw some cell 
death, but not as much as a in our standing culture tests where we saw on average over 
70% cell death as a result of 80mg/ml endolysins exposed to M. smegmatis for 5 hours, 




3.5 Future directions 
The premise for this research is that prophylactic treatments against pathogenic bacteria 
are needed and that bacteriophage endolysins are a promising potential source. Of course, 
one of the first steps to gaining more reliable answers would be to repeat the experiments 
discussed above with more replicates. Three replicates was the minimum required and 
only three were used due to time limitations for submission. 
Although not within the scope of this project, there are several opportunities to expand 
this research and these include; lysin cocktails using a combinatory approach with both 
lysin A and lysin B proteins, a step further with “next generation dual-fusion” nanobeads 
that have both lysin A and lysin B expressed on the surface, inclusion of bacteriophages 
within the cocktail and in vivo tests with other Gram-positive bacterium species (such as 
M. tuberculosis and M. bovis) to further understand the specificity of the lysin proteins 




Since the discovery of bacteriophage over 100 years ago, the appeal of phage therapy is 
on the rise due to the increasing threat of antibiotic resistance in everyday lives. This 
research demonstrated the ability to utilise cell-lysing properties of M. smegmatis’s viral 
predator, the mycobacteriophage, to bypass the opportunity of resistance to the 
bacteriophage by lysing the cell wall “from without”. We fused two lysin A’s and six 
lysin B’s to PHA biodegradable nanobeads and observed significant antimicrobial 
properties against M. smegmatis across three different time points and three different 
endolysin concentrations.  
We started this project with an extensive bioinformatic comparison of potential 
endolysins, which were selected, expressed, produced on nanobeads and purified. We 
successfully tested the antimicrobial properties of these endolysin nanobead fusions 
across four tests. We observed some successful results, especially when M. smegmatis 
was exposed to nanobeads in a standing culture, however, when we employed filter paper 
to mimic a hospital mask with nanobeads coated on the surface we did not see the same 
levels of cell death, although cell death was still present. 
The potential to use the lytic mechanism of the bacteriophage whilst bypassing the 
existing resistance mechanisms of bacteria indicate that this biotechnology is a potential  
key to unlocking a safe, economical, environmentally friendly and most importantly, 
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